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Mobile genetic elements contribute significantly to antibiotic resistance in A. baumannii isolates 
worldwide. In our local hospitals, the genetic arrangement IS1133L/ISAba-1/IS1133R-aacC2a has 
been characterised in strains of A. baumannii spanning more than 23 years.  
Investigation of sequences flanking this arrangement identified a 1 586 bp fragment from an 
EcoRI/HindIII genomic DNA library of A. baumannii strain MOS1. Sequence analysis of this fragment 
indicated that it contained a partial ISKpn12 element upstream of the left end of IS1133. PCR assays 
and sequence analysis using primers that are complementary to ISKpn12 indicated the presence of a 
full copy of ISKpn12 in A. baumannii MOS1. Southern hybridisation studies showed that MOS1 
contains a single copy of ISKpn12 and reverse transcriptase PCR showed that the tnpA of this 
element is expressed during stationary and logarithmic growth phases. Other A. baumannii isolates 
that possess ISKpn12 also carry the IS1133L/ISAba-1/IS1133R-aacC2a conserved genetic 
arrangement, whereas strains that do not carry this conserved region do not contain ISKpn12. This 
finding suggests that ISKpn12 is part of the conserved genetic arrangement that has been identified 
in A. baumannii strains since 1983. The ISKpn12 element was not present in any other nosocomial 
isolates screened including representative isolates of E. coli, P. aeruginosa, and K. pneumoniae. 
A carbapenem resistant A. baumannii strain MOS2 was isolated from the same patient as MOS1, 
following treatment with meropenem. Though MOS2 does not contain the conserved aacC2a-
associated genetic arrangement, it carries at least ten copies of ISAba-1. The role of ISAba-1 was 
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E.     – Escherichia 
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LB   – Luria Bertani 
M   – molar 
MBL     – metallo- -lactamase 
MDR     – multi-drug resistant 
MGE        – mobile genetic element 
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   LITERATURE REVIEW 
 
 
1.1 Microbiology and taxonomy of the Acinetobacter genus 
Acinetobacter (A.) baumannii is an environmental bacterium that has become a major problem 
mainly in the hospital setting. It is a Gram-negative, non-fermentative, and non-motile 
opportunistic pathogen that does not form any spores. Although Acinetobacter species can 
appear Gram-positive on initial Gram stains, they are oxidase-negative, and this helps distinguish 
them from other Gram-negative organisms like Pseudomonas (P.), Neisseria, and Moraxella, 
(Allen & Hartman, 2005). A. baumannii grows on routine laboratory media as smooth, mucoid 
and non-pigmented colonies (Bergogne-Berezin & Towner, 1996). In liquid media, A. baumannii 
has a rod-shaped appearance during rapid growth and a coccobacillary appearance during the 
stationary phase. The morphologic characteristics of A. baumannii may also change depending 
on its exposure to antimicrobial agents (Bayuga et al., 2002; Wilson et al., 2004).  
The genus Acinetobacter was not definitively established until 1971. Today more than 30 
Acinetobacter species have been identified (Juni, 1972; Gerner-Smidt et al., 1991; Vallenet et al., 
2008). Difficulties presented in identification of specific species in the laboratory using phenotypic 
tests have resulted in just 17 Acinetobacter species being named to date (Vallenet et al., 2008). 
In most circumstances, species identification requires molecular techniques like DNA-DNA 
hybridisation (Bouvet & Grimont, 1986), amplified fragment length polymorphisms (Janssen et 
al., 1997), amplified ribosomal DNA restriction analysis (Vaneechoutte et al., 1995), and 
biotyping (Bouvet & Grimont, 1987). Gerner-Smidt and colleagues termed four of their 
phenotypically similar strains Acinetobacter calcoaceticus - A. baumannii complex as standard 
tests could not distinguish them (Gerner-Smidt et al., 1991). 
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1.2 Clinical significance of Acinetobacter baumannii       
With regard to its habitat, A. baumannii is non-selective and is generally widely distributed in soil 
and water (Vallenet et al., 2008). In humans, A. baumannii normally colonises wounds, the skin 
and mucous membranes. Up to 40 % of healthy adults can have skin colonisation, with higher 
rates among hospital personnel and patients (Glew et al., 1977; Villegas & Hartstein, 2003; Allen 
& Hartman, 2005; Munoz-Price & Weinstein, 2008). The respiratory tract, blood, pleural fluid, 
peritoneum, urinary tract, surgical wounds, central nervous system, skin and eyes may be sites 
of infection or colonisation (Al-Khoja & Darrell, 1979; Bayuga et al., 2002; Rodriguez-Bano et al., 
2004). A. baumannii-associated infections include pneumonia, meningitis, septicemia and urinary 
tract infections (Smith et al., 2007). Less frequently, A. baumannii causes skin, soft tissue, 
abdominal, and central nervous system infections (Fournier & Richet, 2006). People mostly likely 
to get A. baumannii infections are those in intensive care units and those with serious underlying 
illnesses (Dijkshoorn et al., 2007). 
Although ubiquitous in the environment, A. baumannii has now become a key nosocomial 
pathogen worldwide. A. baumannii’s fitness in the hospital is mainly a result of its need for simple 
growth requirements, its ability to exploit various nutritional sources, and its ability to grow in a 
wide range of temperatures, pHs, salt concentrations and humidity levels (Bayuga et al., 2002; 
Gusten et al., 2002; Simor et al.,  2002; Iacono et al., 2008). In this regard, A. baumannii shares 
its hardiness and survival abilities with other important Gram-negative nosocomial pathogens like 
Escherichia (E.) coli, Klebsiella spp., P. aeruginosa and Shigella spp. (Kramer et al., 2006). 
 
A. baumannii was susceptible to most antibiotics in the 1970s. This nosocomial pathogen has 
now become a major cause of hospital-acquired infections, partly due to the widespread use of 
antibiotics in hospitals and A. baumannii’s ability to respond rapidly to antibiotic challenge, which 
selects for resistant strains (Thomas, 1998). As a result, multi-drug resistant (MDR) clones of 
A. baumannii are emerging and spreading throughout many geographic areas (Corbella et al., 
2000; Theaker et al., 2003; Van Looveren & Goosens, 2004). The ability of A. baumannii to 










- 3 - 
 
more traditional pathogenic bacteria, which require more time to acquire highly effective 
resistance mechanisms in response to antimicrobial exposure (Bergogne-Berezin & Towner, 
1996).  
 
Previously, reports of A. baumannii community acquired infections were rare (Dijkshoorn et al., 
2007), but this has increased recently (Gootz & Marra, 2008). An increased incidence of 
A. baumannii infections in the community is usually associated with a warm climate (Dijkshoorn 
et al., 2007), cancer (Chen et al., 2001; Anstey et al., 2002; Leung et al., 2006), diabetes mellitus 
(Falagas et al., 2006; Alsultan et al., 2009), chronic obstructive pulmonary disease and/or alcohol 
abuse (Falagas et al., 2006). It is difficult to ascertain the source of these infecting A. baumannii 
strains within communities. A. baumannii isolates obtained from the hospital were thus compared 
with environmental isolates. The latter were entirely susceptible to antibiotics in clinical use, 
whereas the nosocomial isolates had MDR rates of up to 36.6 % (Zeana et al., 2003). This and 
other similar studies revealed that nosocomial isolates were almost always related while the 
environmentally-derived isolates were unrelated, despite the fact that the environmental isolates 
were obtained from the same geographical area (Zeana et al., 2003; Abbo et al., 2005; Longo et 
al., 2006). Poirel and his group discovered carbapenem resistant genes that had spread from 
A. radioresistens isolates to other Acinetobacter species within a hospital setup (Poirel et al., 
2008). These studies by Zeana and Poirel provide strong evidence of how the hospital has 
become the main reservoir of antibiotic resistant determinants. 
    
1.3 Antibiotic resistance mechanisms in Acinetobacter baumannii 
The emergence of antimicrobial resistance in many human pathogenic bacteria has become an 
international problem (Houghton, 2002; Romero et al., 2006; Todd, 2006). Surveillance efforts 
show the development of many genera of bacteria that are resistant to all antibiotics (Gaynes & 
Edwards, 2005; Goossens, 2005). A. baumannii is one such pathogen and deserves close 
attention. Added to its intrinsic antibiotic resistance afforded by decreased membrane 










- 4 - 
 
exceptional and highly impressive ability to rapidly acquire new antibiotic resistance genes from 
other bacterial genera through horizontal gene transfer (Mah et al., 2001; Landman et al., 2002). 
With vertical gene transfer, genes are inherited through cell division (Figure 1.1; Summers, 
2006). Horizontal gene transfer on the other hand is driven by multiple systems, namely 
conjugation, transduction and transformation (Figure 1.2). However, not all bacteria can use all 
three processes. Horizontal gene transfer involves cell-to-cell transfer among closely and 
distantly related bacteria and gene transfer from one DNA molecule to another (Figure1.2; Frost 
& Leplae, 2005; Summers, 2006; Dorman, 2009). The latter can take place regardless of 
similarity between the donating and recipient molecules (Hallet & Sherratt, 1997) and includes 




Figure 1.1:  Vertical i heritance of resistance genes. Bacterial cells are represented by rectangles and their circular 
chromosomes by flattened circles. A spontaneous point mutation is represented by a small dot. Binary propagation 
through hundreds of cell divisions could yield trillions of cells with the same chromosomally borne resistance 















Figure 1.2: Transfer of DNA within and between bacterial cells. Transduction (1). The DNA genome (yellow) of a 
temperate phage inserts into the chromosome (dark blue) as a prophage; it later replicates, occasionally packaging 
host DNA alone (generalized transduction) or with its own DNA (specialized transduction), lyses the cell, and infects 
a naive recipient cell in which the novel DNA recombines into the recipient host cell chromosome (red). Conjugation 
(2). Conjugative plasmids (orange) use a protein structure (known as a pilus) to establish a connection with the 
recipient cell and to transfer themselves to the recipient cell. Alternatively, a copy of a small, multicopy plasmid or 
defective genomic island or a copy of the entire bacterial chromosome can be transferred to a naive cell, in which 
these genetic elements either insert into the chromosome or replicate independently if compatible with the resident 
plasmids (light green).Conjugative transposons and plasmids of Gram-positive bacteria (not shown) do not use pili. 
Transposition (3). Transposons (pink) integrate into new sites on the chromosome or plasmids by non-homologous 
recombination. Integrons (dark green) use similar mechanisms to exchange single gene cassettes (brown). (Taken 
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Phenotypic characteristics that can be acquired through horizontal gene transfer include those 
contributing towards pathogenisis, symbiosis and resistance to antimicrobial agents (Dorman, 
2009). Undoubtedly, pathogens that can rapidly acquire antibiotic resistance have a selective 
advantage over those with more static genomes (Smith et al., 2007). This has resulted in 
bacterial species resistant to an array of clinically useful antibiotics (Segal & Elisha, 1997; 
Hartzell et al., 2007). 
Antibiotic resistance in A. baumannii arises from various intrinsic and acquired mechanisms, 
which are expressed singly or in combination to enable survival of this pathogen in the presence 
of bacteriostatic and bactericidal agents. Such mechanisms include alterations of outer 
membrane and penicillin binding proteins, expression of efflux pumps that exude harmful 
substances, the expression of antibiotic inactivating enzymes, modifications of antibiotic 
resistance genes, and protection of the ribosome from antibiotics that target this macro molecular 
structure. 
 
1.3.1. Alterations of outer membrane proteins and penicillin binding proteins  
Porins are channel forming proteins that allow the transport of molecules across the hydrophobic 
lipid bilayer in bacteria (Garrett & Grisham, 2005). Compared to other Gram-negative bacteria, 
A. baumannii has a reduced number of porins (Sato & Nakae, 1991; Martí et al., 2006). Smaller 
and fewer porins or outer membrane proteins (OMPs) in A. baumannii are associated with 
increased antibiotic resistance (Bou et al., 2000, Fernández-Cuenca et al., 2003, Mussi et al., 
2005). The most commonly described OMP in A. baumannii is the heat-modifiable protein HMP-
AB (Gribun et al., 2003) that belongs to the OmpA family, and is homologous to OprF in 
P. aeruginosa (Vila et al., 2007). This family of channel proteins allow for the diffusion of larger 
solutes that cannot diffuse through smaller OMPs (Nikaido, 2003). 
An investigation of the epidemic of MDR A. baumannii in New York City revealed carbapenem 
resistant isolates with reduced expression of 37-, 44-, and 47- kDa OMPs and increased class C 
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studied and -lactamse enzymes were not investigated. Similarly, in isolates from Madrid, the 
loss of 22-kDa and 33-kDa OMPs combined with the production of OXA-24 resulted in resistance 
to carbapenems (Bou et al., 2000). 
 
A 43-kDa protein in A. baumannii was identified as a homologue of OprD (a well-studied porin 
frequently associated with imipenem resistance in P. aeruginosa; Nikaido, 2003) and was 
involved in carbapenem diffusion (Dupont et al., 2005).  Another channel protein, CarO, a 29-kDa 
OMP which confers resistance to both imipenem and meropenem in A. baumannii, has been well 
characterised (Limansky et al., 2002; Mussi et al., 2005; Siroy et al., 2005). CarO is a non-
specific channel as it does not have any carbapenem-binding sites (Siroy et al., 2005). 
 
OmpW in A. baumannii is similar to its counterpart in E. coli and P. aeruginosa. The role of the 
OmpW OMP in A. baumannii is still unclear; however, its expression was decreased in an in vitro 
colistin-resistant A. baumannii mutant (Sara Martí, unpublished data in Vila et al., 2007). 
Previously, OmpW expression was severely decreased in a ceftriaxone-resistant Salmonella 
Typhimurium strain (Hong et al., 2006) and it may be that OmpW might also be involved in the 
uptake of this antibiotic in A. baumannii (Vila et al., 2007). It will be necessary to carry out further 
studies to elucidate the role of OMPs in MDR A. baumannii. It would also be essential to 
characterise the structure of the outer membrane of A. baumannii that confers its special 
permeability features (Vila et al., 2007). 
 
Of the few studies undertaken, there is variability in the number of observed OMPs in 
A. baumannii (Cuenca et al., 2003) and a similar pattern exists for penicillin binding proteins 
(PBPs) (Fernándes-Cuenca et al., 2003). Resistance to carbapenems can also be explained by 
the reduced expression of PBP-2 in A. baumannii (Fernandes-Cuenca et al., 2003). Noteably, 
these strains had no OMPs and produced β-lactamases, illustrating the interaction of different 
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1.3.2. Efflux pumps 
Efflux pumps represent a single mechanism causing resistance against several compounds toxic 
to the bacterial cell, including different antibiotic classes (Perez et al., 2007). Various classes of 
efflux pump families exist among the different bacterial species (Poole, 2005) and the AdeABC 
efflux pump in A. baumannii belongs to the resistance-nodulation-cell division family. This pump 
is responsible for the resistance of A. baumannii against aminoglycosides, cefotaxime, 
tetracyclines, erythromycin, chloramphenicol, trimethoprim, and fluoroquinolones (Magnet et al., 
2001). High-level carbapenem resistance can be achieved by the increased expression of the 
AdeABC efflux pump combined with class D β-lactamases expression (Marqué et al., 2005). 
AdeABC overexpression is a result of point mutations in either the adeR or adeS genes that 
make up a two step regulator (adeR) and sensor (adeS) system (Marchand et al., 2004). 
Another multidrug efflux pump, AbeM, belonging to the multidrug and toxic compound extrusion 
family has been described in A. baumannii (Su et al., 2005). Unlike the AdeABC efflux pump, the 
AbeM has substrate specificity and is responsible for the efflux of fluoroquinolones, trimethoprim, 
and aminoglycosides (Su et al., 2005). This pump is similar to a PmpM pump in P. aeruginosa, 
VcmA in Vibrio parahaemolyticus, YdhE in E. coli and HmrH in Haemophilus influenzae (Su et 
al., 2005). 
 
1.3.3. Enzymatic inactivation of β-lactams 
The β-lactam antibiotics are the antibiotics of choice in treatment of severe A. baumannii 
infections. This class of antibiotics includes penicillin derivatives, cephalosporins, monobactams, 
β-lactamase inhibitors and carbapenems (Holten & Onusko, 2000). Carbapenems are one of the 
last resort antibiotics left to treat A. baumannii infections, unfortunately, resistance to 
carbapenems is steadily increasing (Henwood et al., 2002; Nordmann & Poirel, 2002; Segal et 
al., 2004; Poirel & Nordmann, 2006a; Turton et al., 2006; Le Hello et al., 2008; Mugnier et al., 
2009) and this causes great concern as the rate of antibiotic resistance doesn’t match the rate of 
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Different mechanisms of β-lactam resistance have been reported and identified in A. baumannii 
and these include β-lactamase production (Danes et al., 2002; Brown & Amyes, 2006; Dorsey et 
al., 2006; Qi et al., 2008; Kansal et al., 2009), penicillin binding protein alterations (Fernández-
Cuenca et al., 2003), activity of efflux pumps (Perez et al., 2007),  and reduced penetration 
across the outer membrane porins (Bou et al., 2000; Limansky et al., 2002; Quale et al., 2003).  
Nevertheless, β-lactamase production is the primary cause of resistance (Corvec et al., 2003; 
Hall & Barlow, 2005; Ruiz et al., 2007) or is often linked with other resistance mechanisms in the 
same antibiotic resistance strain (Bou et al., 2000; Fernándes-Cuenca et al., 2003). 
The most commonly used classification of β-lactamases is the Ambler classification (Ambler, 
1980) that divides β-lactamases into four classes (Classes A, B, C and D; Ambler, 1980), based 
on their amino acid sequences. Class A, C, and D β-lactamases share a common β-lactam 
hydrolysis mechanism with the amino acid serine as their active site (Ambler, 1980; Jaurin & 
Grundstrom, 1981; Ouellette et al, 1987). Class B β-lactamases on the other hand require a 
bivalent metal ion, mostly Zn2+, for activity (Ambler, 1980, Hall & Barlow, 2005). 
 
1.3.3.1. Class A β-lactamases 
The class A β-lactamase variants temoniera (TEM), sulfhydryl (SHV), VEB, PER and CTX-M, 
have been detected mostly in Enterobacter cloacae, Serratia marcescens, and Klebsiella spp. 
but more recently in Acinetobacter spp. (Gootz & Marra, 2008; Walther-Rasmussen & Høiby, 
2004; Vila et al., 1993). Class A β-lactamases are present in A. baumannii isolates from all over 
the world. A. baumannii harboring the integron-borne VEB-1 has caused outbreaks in French 
and Belgian hospitals (Naas et al., 2006a; Naas et al., 2006b, Poirel et al., 2003). SHV-12-
producing A. baumannii strains have been reported in China (Huang et al., 2004). In addition, an 
A. baumannii isolate harbouring both SHV-12 and TEM-116 was identified in Netherlands 
(Naiemi et al., 2005). In Italy, TEM-92 was found in A. baumannii isolates (Endimiani et al., 
2007). CTX-M-2, an extended spectrum β-lactamase (ESBL) that hydrolyses cefotaxime and 
ceftriaxone, was found in epidemic strains of A. baumannii in a neurosurgical ward in Japan, as 
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Interestingly, the dissemination of the blaCTX-M gene is not as widespread in Acinetobacter spp. 
as among Enterobacteriaceae (Perez et al., 2007; Gootz & Marra, 2008). A. baumannii strains 
with PER-1 demonstrate high-level resistance to penicillins and extended-spectrum 
cephalosporins but not to carbapenems (Perez et al., 2007) and such strains are mostly 
prevelant in Turkey, Korea, France, Belgium, and Bolivia (Yong et al., 2003; Kolayli et al., 2005; 
Poirel et al.,  2005a; Celenza et al., 2006; Naas et al., 2006b). In 2006, a molecular and 
epidemiological analysis described PER-1 for the first time in the United States (Hujer et al., 
2006).  
 
Another class A β-lactamase, SCO-1 was identified in A. baumannii (Poirel et al., 2007; 
Papagiannitsis et al., 2007). This enzyme has a 40 % homology to other known class A β-
lactamases and hydrolyses penicillin at high levels.  However, SCO-1 hydrolyses carbapenems 
and cephalosporins at very low levels. The blaSCO-1 gene has been identified on a 150 kilobase 
(kb) plasmid (Poirel et al., 2007) where it was associated with an umuDC-type operon (Poirel et 
al., 2007) that encodes umuD and umuC proteins involved in SOS responses (Smith & Walker, 
1998).  
Generally, detection of the level of resistance of ESBLs in A. baumannii is complicated by the 
presence of chromosomal cephalosporinases. Therefore, it is often uncertain to what extent 
class A ESBLs are distributed in A. baumannii (Perez et al., 2007). 
 
1.3.3.2. Class B β-lactamases 
Metallo-β-lactamases (MBLs) can hydrolyze carbapenems and every other β-lactam antibiotic 
except aztreonam (Walsh, 2005; Walsh et al., 2005). This class of β-lactamases was first 
described in a strain of P. aeruginosa found in Japan in 1988 (Watanabe et al., 1991). MBLs 
have now been identified in most Gram-negative bacteria including Acinetobacter genomic 
species 13 TU (Poirel & Nordmann, 2006a; Lim et al., 2007). However, only three types of 
metallo-β-lactamases, IMP, Verona-integron-encoded MBL (VIM), and Seoul-imipenemase 
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2004; Walsh et al., 2005; Franklin et al., 2006), all of which were initially identified in 
Pseudomonas species (Lauretti et al., 1999; Lee et al., 2005). As the MBLs are not intrinsic to 
A. baumannii, there is increasing evidence that they were acquired from a reservoir, 
P. aeruginosa, in the hospital setting (Walsh et al., 2005; Lolans et al., 2005; Toleman et al., 
2005; Hanson et al., 2006), highlighting the important continuous flow of genetic information 
within the hospital environment. 
IMP MBLs in A. baumannii are usually detected as part of a class 1 integron (Huang et al., 2008). 
Several IMP MBLs have been described so far: IMP-1, IMP-2, IMP-4, IMP-5, IMP-6, and IMP-11 
(Walsh, 2005; Walsh et al., 2005). Most of the IMP β-lactamases in A. baumannii have been 
reported in Japan (Nishio et al., 2004), but they seem to have first appeared in Hong Kong (Chu 
et al., 2001). An MBL in A. baumannii in the Americas has been reported from an IMP-producing 
isolate from Brazil (Gales et al., 2003; Tognim et al., 2006). 
The broad-spectrum SIM-1 MBL possesses 69 % identity with IMP-12 MBL and 64 % identity 
with IMP-9 MBL. There is intriguing genetic evidence to suggest that the blaSIM-1 cassette may 
have originated from the P. alcaligenes In55044 superintegron (Lee et al., 2005). Thus far, SIM-1 
has only been reported in A. baumannii isolates from South Korea (Lee et al., 2005), where this 
determinant might also be prevalent (Park et al., 2005). 
 
VIM-1 MBL was first identified in 1997 in Italy in a P. aeruginosa isolate (Lauretti et al., 1999); 
A. baumannii harboring VIM-2 has been reported in Korea (Weldhagen, 2004). Both variants are 
often associated with class 1 integrons in A. baumannii (Poirel & Nordman, 2002; Yum et al., 
2002; Weldhagen, 2004). 
IMP and VIM β-lactamases have stronger hydrolytic activity against carbapenems than do 
carbapenem-hydrolyzing oxacillinases while the SIM variant confers a moderate level of 












- 12 - 
 
1.3.3.3. Class C β-lactamases  
All A. baumannii isolates, like other Gram-negative organisms, have a chromosomally encoded 
ampC cephalosporinase gene much like the species specific ampC gene in E. coli (Gootz & 
Marra, 2008). The class C cephalosporinases hydrolyze penicillins and narrow-spectrum and 
extended-spectrum cephalosporins, but not cefepime or carbapenems (Morohoshi & Saito, 
1977).  The ampC gene is not inducible with β-lactams, therefore it is normally expressed at low 
levels (Joly-Guillou et al, 1988; Blechschmidt et al., 1992; Perilli et al., 1996; López-Hernández et 
al., 2001; Poirel & Nordmann, 2006b). Thus, many clinical isolates of A. baumannii are resistant 
to ceftazidime (Joly-Guillou et al., 1987; López-Hernández et al., 2001). Sequence analysis of 
ampC flanking regions has failed to identify the presence of any of the regulatory regions, ampR 
or ampD (Perilli et al., 1996). Nevertheless, the presence of an insertion sequence, ISAba-1, 
upstream of the ampC gene has been associated with increased levels of resistance to β-
lactams in A. baumannii isolates by providing promoter sequences within this IS element (Corvec 
et al., 2003; Segal et al., 2004). 
 
1.3.3.4. Class D β-lactamases 
The most common carbapenemases detected in A. baumannii are carbapenem-hydrolyzing 
oxacillinases (Poirel & Nordmann, 2006a). There exists nine clusters of carbapenem-hydrolyzing 
oxacillinases (Walther-Rasmussen & Høiby, 2006; Queenan & Bush, 2007) of which four, 
including, OXA-23-like, OXA-40-like, OXA-51/69-like and OXA-58, have been identified in 
A. baumannii. The first description of such an OXA carbapenemase in A. baumannii was OXA-
23, which was obtained from a clinical isolate found in Scotland in 1985 before the introduction of 
carbapenems. Since then, this plasmid-encoded enzyme, initially named ARI-1 (acinetobacter 
resistant to imipenem) has been discovered internationally (Dalla-Costa et al., 2003; Jeon et al., 
2005; Brown & Amyes, 2006; Segal et al., 2007).  The OXA-23-like group consists of OXA-23, 
OXA-27, and OXA-49. OXA-24, OXA-25, OXA-26, and OXA-40 constitute the second group 
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carbapenemases include OXA-64, OXA-65, OXA-66, OXA-68, OXA-70, OXA-71, OXA-78, OXA-
79, OXA-80, OXA-82 (Perez et al., 2007), OXA-90, OXA-130, OXA-131, and OXA-132 (Alsultan 
et al., 2009).The OXA-51/69-like β-lactamases are naturally occurring chromosomal enzymes in 
A. baumannii; they have been identified in isolates from all over the world, and their expression 
varies according to the presence of the insertion sequence, ISAba-1 (Poirel & Nordmann, 2006a; 
Alsultan et al., 2009). OXA-58, a plasmid-borne carbapenemase, (Poirel et al., 2005b; Qi et al., 
2008) has been  identified in strains from France, England, Argentina, Spain, Turkey, Romania, 
Austria, Greece, Scotland, and Kuwait (Marque et al., 2005; Coelho et al., 2006;  Pournaras et 
al., 2006). All these variants of carbapenem-hydrolyzing oxacillinases were initially identified in 
carbapenem resistant clinical isolates of A. baumannii (Brown & Amyes, 2006; Dorsey et al., 
2006; Qi et al., 2008).  
The significant contribution of class D β-lactamases to carbapenem resistance in A. baumannii 
has been emphasised, particularly when they are accompanied by ISAba-1 and ISAba-3 
(Marque et al., 2005). The widespread presence of Class D β-lactamases may indicate that 
oxacillinases are also an essential component of the genetic make-up of Acinetobacter spp. 
(Walther-Rasmussen & Høiby, 2006).  
 
1.3.4. Resistance to aminoglycosides 
The aminoglycoside antibiotics function by specifically binding to an aminoacyl site on the 16S 
rRNA of the 30S ribosomal subunit where they interfere with bacterial protein synthesis (Magnet 
& Blanchard, 2005). While nucleotide substitution of the aminoacyl site, decreased membrane 
permeability, and the previously described AdeABC multidrug efflux pump play a role in 
aminoglycoside resistance, it is the aminoglycoside-modifying enzymes (AMEs) that mainly 
mediate resistance to aminoglycosides in A. baumannii. Aminoglycoside resistance by AMEs is a 
major unwelcome feature in the multidrug-resistant phenotype of A. baumannii (Bergogne-
Berezin & Towner, 1996) and is mediated by the alteration of the amino- or hydroxyl groups of 
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phosphotransferases, acetyltransferases, and nucleotidyltransferases, most of which are 
encoded on integrons (Table 1.1).  Resistance to aminoglycosides as a result of the activity of all 
three types of AMEs has been identified in A. baumannii (Bergogne-Berezin & Towner, 1996; 
Seward et al., 1998; Nemec et al., 2004).  
 
Table 1.1: Aminoglycoside modifying enzymes reported in A. baumannii 
Enzyme Substrate Reference 
Acetylating   
AAC(2')I Gm, Neo, Tob Dowding, 1979; Elisha & Steyn, 1991 
AAC(3)I  Gm Vila et al., 1993 
AAC(3)II Gm, Tob, Net Murray & Moellering, 1980; Elisha & Steyn, 1994 
AAC(3)Va  Gm, Tob Elisha & Steyn, 1991;  Shaw et al., 1993 
AAC(3)IV Gm, Tob Shaw et al., 1993 
AAC(6')  
 
Amik, Km, Tob 
 
Lambert et al., 1990;  Lambert et al., 1993; Murray & Moellering, 1979;  
Shannon et al., 1978 
Adenylating   
AAD(2'') Gm, Km, Tob Shaw et al., 1993; Elisha & Steyn, 1994; Segal & Elisha, 1997 
AAD(3'')(9)a 
  
Devaud et al., 1982; Goldstein et al, 1983;  Murray & Moellering, 1980;  
Vila et al., 1993 
ANT(2'')I  Gm, Km, Tob Murray & Moellering, 1979 
ANT(3'')I  Sm Shannon et al., 1978 
   





Devaud et al., 1982;  Goldstein et al, 1983;  
Shaw et al., 1993 
APH(3'')I Sm Elisha & Steyn, 1989 
APH(3')II  Km, Neo Murray & Moellering, 1979 





Lambert et al., 1988; Martin et al., 1988; Lambert et al., 1990; 
Shaw et al., 1993; Vila et al., 1993 
APH(3'')VI Amik, Km, Neo Bergogne-Bérézin & Towner, 1980 
   
Modification of a table from Bergogne-Bérézin & Towner, 1996. 
a Enzymatic activity detectable only in vitro.  
Amik, amikacin; Km, Kanamycin; Tob, Tobramycin; Gm, Gentamycin; Neo, Neomycin; Net, Netilmicin; Sm, Streptomycin 
 
 
Similar AMEs can be found in unrelated isolates of Acinetobacter spp. and particular genes are 
not necessarily restricted to specific regions of the world. Hence, similar integrons have been 
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Seward, 1999). This finding has been confirmed throughout Europe (Gallego & Towner, 2001; 
Nemec et al., 2004; Turton et al., 2005), where a remarkably stable class 1 integron with the 
same variable region was retrieved from isolates that are genotypically unrelated, indicating their 
importance in the dissemination of antibiotic resistance genes. Some strains habour more than 
one aminoglycoside resistance gene, with as many as six different resistance genes being 
identified in some isolates (Bergogne-Bérézin & Towner, 1996). 
A novel gene aac(6′)-Ig, was identified in A. haemolyticus, where it confers resistance to 
amikacin (Lambert et al., 1993). This gene has not been identified in any other species and may 
be used to facilitate the identification of this Acinetobacter spp. (Lambert et al., 1993).   
Aminoglycoside resistance in A. baumannii may be due to methylation of the 16S ribosomal RNA 
(Lee et al., 2006), a common mechanism used by other bacterial species (Doi & Arakawa, 2007; 
Doi et al., 2007). Naturally occurring aminoglycosides are synthesised by some Actinomycete 
spp., which in turn are intrinsically resistant to this group of antibiotics (Cundliffe, 1989). Intrinsic 
aminoglycoside resistance in Actinomycete spp. is mostly a result of ribosomoal protection due to 
the methylation of specific nucleotides within the aminoacyl site on the 16S rRNA in the 30S 
ribosomal subunit by methylase enzymes. This way, the aminoglycosides will not bind to the 30S 
ribosomal subunit, and so serves as a self defense mechanism (Cundliffe, 1989). Unfortunately, 
this resistance mechanism has been identified in pathogenic bacteria (Doi & Arakawa, 2007). 
The 16S rRNA methylases are often located on transposons within conjugative plasmids, hence 
their widespread identification in nosocomial pathogens (Benveniste & Davies, 1973; Galimand 
et al., 2003; Galimand et al., 2005; González-Zorn et al., 2005; Wachino et al., 2006a; Wachino 
et al., 2006b; Doi et al., 2007). 
 
1.3.5. Resistance to fluoroquionolones 
Fluoroquinolones inhibit bacterial DNA synthesis by targeting the DNA gyrase (GyrA-GyrB) and 
topoisomerase IV (ParC-ParE) proteins, which have essential functions in DNA replication. 
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gyrase mediated by mutations in the quinolone resistance gyrA and parC genes (Vila et al., 
1995; Vila et al., 1997; Seward & Towner, 1998; Eliopoulos, 2004). These changes result in a 
lower affinity for the binding of the quinolone to the DNA-enzyme complex. 
The first plasmid-mediated quinolone resistance gene, qnrA, was reported in 2002 from a 
Shigella dysenteriae isolate (Tran & Jacoby., 2002). It encodes a protein QnrA, which binds to 
the gyrase and prevents its inactivation by fluoroquinolones. Other gyrase-protecting proteins, 
QnrB in Klebsiella (K.) pneumoniae (Jacoby et al., 2006), QnrC in Proteus mirabilis (Wang et al., 
2009), and QnrS, have been identified on plasmids. Genes encoding QnrA and QnrB occur as 
integron cassettes and are seen increasingly in bacterial isolates obtained from infected patients 
worldwide (Tran & Jacoby, 2002; Jacoby et al., 2006; Summers, 2006). The plasmid-mediated 
quinolone resistance genes, qnrA and qnrB, and the gene encoding the AME with the capacity to 
modify ciprofloxacin (aac(6’)-lb-cr) have not been detected in A. baumannii (Cattoir & Nordmann., 
2009), but have been identified in other Gram-negative bacteria, including Enterobacter and 
Klebsiella species (Robicsek et al., 2005). It will be interesting to determine whether the spread 
of integron-based qnr genes diminishes the occurrence of the gyrase mutants (Summers, 2006). 
 
In A. baumannii, fluoroquinolone resistance also results from reduced outer membrane 
permeability, or over expression of the non-specific AdeABC efflux pump (Magnet et al., 2001). 
Fluoroquinolone resistance in A. baumannii could also be the result of the expression of the 
substrate specific AbeM efflux pump, as revealed by expression studies of an A. baumannii 
abeM gene cloned into E. coli (Su et al., 2005).  
 
 
1.3.6. Resistance to tetracyclines 
In bacteria, tetracycline inhibits protein synthesis by binding to the 30 S ribosomal subunit 
(Roberts, 1996). Mechanisms contributing to tetracycline resistance include the effect of efflux 
pumps, and ribosomal protection. TetA and TetB are specific transposon-mediated efflux pumps; 
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only (Guardabassi et al., 2000; Huys et al., 2005). Ribosomal protection is mediated by a protein, 
TetM, which has 100 % homology to the S. aureus counterpart (Ribera et al., 2003). TetM 
shields the ribosome from the action of tetracycline, doxycycline, and minocycline (Bertrand et 
al., 2005). 
Tigecycline, a representative of a new class of antibiotics, glycylcyclines, is related to 
tetracyclines and is often used to treat complicated skin and intra-abdominal infections (Institute 
of Medicine, 1998). Bloodstream infections caused by tigecycline-resistant A. baumannii isolates 
have been reported (Peleg et al., 2007; Ruzin et al., 2007). Resistance to tigecycline in 
A. baumannii isolates was a result of the over expression of AdeABC efflux pumps (Ruzin et al., 
2007). The tigecycline-resistant strains had the AdeRS two-component system, which regulates 
AdeABC efflux pump expression, disrupted by the insertion sequence ISAba-1. The insertion of 
ISAba-1 resulted in an over expression of adeABC by providing promoter sequences for this 
operon (Ruzin et al., 2007). TetX, a plasmid-borne flavin-dependent mono-oxygenase degrades 
tigecycline; however, this enzyme has not been identified in A. baumannii clinical isolates (Moore 
et al., 2005).  
 
1.3.7. Resistance to polymyxins 
Polymyxin B and polymyxin E (colistin) are peptide antibiotics isolated from Bacillus colistinus 
(Montefour et al., 2008). Colistin became commercially available in 1959; but due to its 
nephrotoxicity it was rarely used. However, in the absence of less toxic antibiotics with activity 
against MDR A. baumannii, colostin is being used more frequently. Colistin acts as a cationic 
detergent, resulting in modifications in the lipopolysaccharide of A. baumannii by acidification, 
acylation, or presence of antigens that interfere with binding of the antibiotic to the cell 
membrane (Peterson et al., 1987; Montefour et al., 2008).  As a result, intercellular substances 
leak through the bacterial membrane, resulting in cell death (Montefour et al., 2008). Reports of 
resistance to colistin in A. baumannii raise concern about the long term use of this antibiotic 
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At Groote Schuur hospital (GSH) in South Africa, carbapenem resistant A. baumannii isolates 
are on the increase and colistin is administered as the last treatment option (Gounden et al., 
2009). Fortunately, there have not been any reported cases of resistance or adverse side effects 
to colistin in this hospital (Gounden et al., 2009). 
 
1.4. The role of mobile genetic elements in antibiotic resistance in Acinetobacter 
baumannii 
Bacterial DNA is highly dynamic and the genetic content of bacterial species is in permanent flux 
(Schmidt & Hensel, 2004). Microbial genomes can host variable and frequently significant 
amounts of foreign DNA, with E. coli and Salmonella enterica genomes comprising up to 17 % of 
foreign DNA (Ochman et al, 2000). Horizontal gene transfer is an important mechanism which 
seems to be the primary force by which bacteria genetically adapt to novel environments and by 
which bacterial populations diverge and form separate, evolutionary distinct species (Ochman et 
al, 2000; Schmidt & Hensel, 2004).   
 
Mobile genetic elements (MGEs) carry genes that encode proteins responsible for the process of 
horizontal gene transfer (Frost & Leplae, 2005). These elements also harbour clusters of 
resistance genes, the proteins of which confer resistance to several unrelated families of 
antibiotics (Milkman, 1999; Hacker & Carniel, 2001). There are generally two groups of MGEs; 
those that are transferable between bacterial cells and those transferable within the same 
bacterial cell from one genetic location to another (Sobecky & Hazen, 2009; Frost & Leplae, 
2005). Plasmids and conjugative resistance transposons make up the group of MGEs 
transferable between cells. Those MGEs with the ability to move between genetic locations 
within a bacterial cell include resistance transposons, gene cassettes and insertion sequence 
elements. This second group of MGEs is transferable between bacterial cells when located on 
mobile plasmids (Hacker & Carniel, 2001; Sobecky & Hazen, 2009). MGEs therefore contribute 
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1.4.1. Plasmids  
Plasmids are small, circular, secondary, dispensable chromosomes. Plasmids are found in 
essentially all types of bacteria and so constitute a large pool of mobile genetic information (Mims 
et al., 2004). These DNA molecules have the ability to promote their own transfer between 
bacterial cells and so they play a significant role in bacterial adaptation and evolution (Snyder & 
Champness, 2002). Plasmids range in size from 2 kb, comprising 2 or 3 genes, to 10% or more 
of the host cell chromosome, accommodating at least 400 genes (Snyder & Champness, 2002). 
This sub-group of MGEs does not accommodate the core genes needed by the cell for basic 
growth and reproduction, but rather carry genes that may be periodically useful to enable the cell 
to exploit particular environmental conditions, like the ability to survive and thrive in the presence 
of potentially lethal antibiotics (Snyder & Champness, 2002).  
 
Plasmids replicate independently of the main bacterial chromosome, although most replication 
functions are provided by the host cell. Conjugative plasmids allow for the transfer of plasmids 
between bacterial cells and can exhibit broad or narrow host range (Mims et al., 2004; Bennett, 
2008). For the latter, transfer is restricted generally to and between a small number of similar 
bacterial species. Broad host range denotes an element able to transfer between widely different 
bacterial species. The determinant of host range has not been widely investigated, but one 
possibility is that it reflects the nature of the surface receptor on the potential recipient cell 
needed by the particular conjugation machinery of the plasmid (Snyder & Champness, 2002; 
Bennett, 2008). If the potential recipient cell lacks this structure, then plasmid transfer to it will not 
occur. If distribution of the receptor is limited, then the plasmid will exhibit a narrow host range. 
Another possibility is that although transfer of the plasmid is successful, the recipient cell is 
unable to support its replication (Snyder & Champness, 2002; Bennett, 2008).  Although multiple 
plasmid carriage is very common (Snyder & Champness, 2002) a plasmid belonging to a different 
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Plasmid-encoded antibiotic resistance encompasses most, if not all classes of antibiotics 
currently in clinical use and includes resistance to many that are at the forefront of antibiotic 
therapy (Montefour et al., 2008). More than 25 years ago it was demonstrated that 
Acinetobacter spp. can acquire antimicrobial resistance factors through plasmid conjugation 
(Goldstein et al., 1983) and that plasmids can readily differ among A. baumannii strains (Murray 
& Moellering, 1980). In the early 1990s, plasmids had been identified in nearly 80 % of multi-
resistant isolates of Acinetobacter (Gerner-Smidt, 1989; Seifert et al., 1994). However, there had 
been a few examples in which plasmid-mediated transfer of resistance genes in Acinetobacter 
was demonstrated and this could have been a reflection of the absence of suitable test systems 
for detecting such transfer at that time (Seifert et al., 1994). By the turn of the century, there has 
been an increased recovery of plasmid-encoded resistance genes from A. baumannii (Héritier et 
al., 2005; Poirel et al., 2005; Bertini et al., 2007; Segal et al., 2007). 
Carbapenem-hydrolyzing oxacillinases represent the main mechanism of resistance to 
carbapenems in Acinetobacter spp. (Bonomo & Szabo, 2006). The oxacillinase-encoding genes 
are mostly located on transferable plasmids (Héritier et al., 2005; Poirel et al., 2005; Bertini et al., 
2007).  Attempts to transfer the oxacillinase genes from A. baumannii to E. coli as the recipient 
strain failed either because the plasmids possess restricted host ranges (Bertini et al., 2007; 
Héritier et al., 2005; Poirel et al., 2005)  or because the transcriptional regulatory sequences in 
A. baumannii and E. coli differ (Segal & Elisha, 1999). 
The carbapenem resistance conferring gene blaOXA-23 is almost always associated with the 
insertion sequence ISAba-1 in A. baumannii isolates (Corvec et al., 2007). A 60 kb plasmid 
obtained from various A. baumannii isolates in France had such an arrangement (Le Hello et al., 
2008). It may be that A. radioresistens acts as a source of the blaOXA-23-like gene family currently 
emerging as the source of carbapenem resistance in A. baumannii worldwide (Corvec et al., 
2007; Poirel et al., 2008). A model proposed is that a plasmid-mediated ISAba-1 element 
originating from A. baumannii transposed into A. radioresistens targeting flanking regions of a 
chromosomal blaOXA-23-like gene. This would have formed a transposon-like structure and also 
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then transposed and targeted a plasmid within the A. radioresistens genome. In turn, this 
resultant plasmid may have conjugated into A. baumannii, thus spreading the resistance 
determinant in the latter species. It is possible that the genetic exchange between these two 
species may have occurred in humans, since both A. baumannii and A. radioresistens are 
identified on the human skin, especially in hospitalised patients (Seifert et al., 1997; Berlau et al., 
1999; Poirel et al., 2008). The identification of the same plasmid types in A. radioresistens and 
A. baumannii provides further evidence for gene exchange between those two species (Poirel et 
al., 2008). 
An epidemic, multidrug-resistant A. baumannii strain ACICU from Italy harbours a single 
chromosome and two plasmids, pACICU1 and pACICU2. Carbapenem resistance in 
A. baumannii ACICU is conferred by the OXA-58 oxacillinase, whose gene was detected in the 
plasmid pACICU1 (Iacono et al., 2008). Plasmid pACICU1 carried two copies of the blaOXA-58 
gene, and these likely originated from direct repetition of the ISAba-2-blaOXA-58-ISAba-3 mobile 
element (Iacono et al., 2008). The duplication of the blaOXA-58 gene has also been described in 
other unrelated A. baumannii strains and is generally associated with increased resistance to 
imipenem and meropenem (Bertini et al., 2007). The duplication of this genetic determinant was 
probably facilitated by the presence of multiple IS26 elements dispersed within the plasmid 
region (Bertini et al., 2007; Iacono et al., 2008). 
 
Another plasmid-located blaOXA-58 conferring carbapenem resistance to A. baumannii was 
described (Chen et al., 2008). The plasmid pTVICU53, recovered from an A. baumannii clinical 
isolate in Taiwan, contained open reading frames (ORFs) from multiple origins including plasmid 
pMAC (from A. baumannii ATCC 19606T), plasmid pAB2 (from A. baumannii ATCC 17978; 
GenBank accession number CP000523), plasmid pKLH201 (from A. calcoaceticus KHW14; 
GenBank accession number AJ251307), and the A. baumannii genome (of ATCC 17978; 
NC_009085). Hybrid IS elements, IS1008 and ISAba-3, were also observed upstream of the 
blaOXA-58 on pTVICU53. Electro-transformation of the original or recombinant plasmid into 
different A. baumannii strains conferred a 64- to 256-fold increase in their carbapenem minimum 










- 22 - 
 
carbapenem resistance (Chen et al., 2008). Transformation of shuttle vector pOXA-58-3, bearing 
IS1008-ISAba-3-blaOXA-58, into E. coli provided only a mild increase in carbapenem MICs (<2 
μg/ml) observed. Similar results, where mild resistance to carbapenems was observed following 
transformation of resistance plasmids into E. coli, had previously been demonstrated by Héritier 
and colleagues (2005). Although carbapenem resistance was insignificant in the transformed 
E. coli, Southern hybridisation experiments revealed the presence of the plasmid-borne blaOXA-58 
in this host (Chen et al., 2008). This observation could mean that the plasmids in A. baumannii 
have promoter sequences different from those recognised in E. coli (Segal & Elisha, 1999) or 
that other co-factors from A. baumannii were required for the full function of carbapenem 
resistance (Chen et al., 2008).  
A site-specific recombination mechanism was observed on an 8.963 kb plasmid, pABVA01, from 
an OXA-24-producing A. baumannii strain VA-566/00 from Italy (D’Andrea et al, 2009). 
Comparative analysis with other sequenced A. baumannii plasmids revealed that the genetic 
organisation of pABVA01 was very similar to that of p2ABAYE (Vallenet et al., 2008) and of 
pAB0057 (Adams et al., 2008), two small Acinetobacter plasmids previously detected in French 
and American clinical isolates, respectively. One of the major differences between pABVA01 and 
those plasmids was in the region containing blaOXA-24. In p2ABAYE and pAB0057, blaOXA-24 was 
replaced by unique regions of different size and composition (Figure 1.3a and 1.3b). A similar 
arrangement of intervening DNA modules inserted at the same position suggested the 
occurrence of a conserved recombination site where different DNA modules could be inserted by 
a site-specific recombination mechanism (D’Andrea et al, 2009). Analysis of the sequences at 
the recombination junctions revealed, on both sides, the presence of conserved inverted repeats 
(IRs) separated by a 6 base pair (bp) variable region. These structures share high homology with 
dif-like binding sites which act as targets of the XerC and XerD recombinases that normally 
convert plasmid and chromosome dimers to monomers during cell division (Summers & Sherratt, 
1988). XerC and XerD proteins and similar recombination sites are also involved in other site-
specific recombination mechanisms such as the integration of phage CTX-Φ at the dif1 site of 
the Vibrio cholerae larger chromosome (Val et al., 2005). They have also been exploited for 
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Cranenburgh, 2006). These findings suggest that the XerC/XerD-like sites could act as site-
specific recombination targets responsible for mobilisation of discrete DNA modules within 
Acinetobacter plasmids and chromosomes, and that blaOXA-24 could be mobilised by a similar 
mechanism. 
 
Figure 1.3: (a) Linear map of plasmid pABVA01. The dashed line indicates the sequenced region of plasmid from 
isolate VA-566/00 (b) Comparison of plasmid pABVA01 with plasmids p2ABAYE and pAB0057. For each segment 
of homology the percentage of nucleotide identity and gaps inserted into alignments are shown. Filled boxes 
represent the putative recombination sites represented by the IRs homologous to the XerC/XerD binding sites. Sizes 
of the different DNA modules inserted between the IRs in place of the blaOXA-24 module are also shown (Taken from 
D’Andrea et al., 2009).  
 
Analysis of the genetic context of blaOXA-24 did not reveal structures typically involved in DNA 
mobilisation (insertion sequences, transposons, integrons or other genes encoding known 
recombinases; D’Andrea et al 2009). However, blaOXA-24 was carried on a DNA module inserted 
between conserved inverted repeats homologous to XerC/XerD binding sites which, in other 
plasmids, flank DNA modules of different sizes and compositions. This suggests the occurrence 
of a unique site-specific recombination method that may play a role in the plasticity of 
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1.4.2. Transposons 
Transposons are non-self-replicating genetic elements. They can move independently between 
DNA molecules within bacterial cells, but require plasmids or bacteriophages to move between 
cells (Figure 1.2) (McClintock, 1950; Frost & Leplae, 2005; Summers, 2006). These genetic 
structures contain inverted repeats, a transposase gene and at least one antibiotic resistance 
gene, for example tetracycline resistance in Tn10 or ampicilin resistance in Tn3. Thus, 
transposons differ from IS elements in that they encode at least one functional gene that 
changes the phenotype of the cell in a predictable fashion (Summers, 2006). Transposons are 
differentiated by their structure, genetic relatedness and transposition mechanism, which does 
not generally require DNA homology between the transposon and insertio  site (Bonafede et al., 
1997; Frost & Leplae, 2005; Summers, 2006). 
Transposons jump randomly within bacterial cells and occasionally integrate into each other 
resulting in mosaic structures in which highly recombinog nic regions are included (Bonafede et 
al., 1997; Culebras & Martinez, 1999; Summers, 2006;). One such example is the transposon 
Tn21 in which the transposable integron In2 integrated into a mercury resistant transposon 
related to Tn501 (Summers, 2006).Thus, the acquisition of novel traits is a common occurrence 
in transposon evolution (Bonafede et al., 1997). Transposons could therefore either be 
composite or complex systems. In composite transposons, a non-transposable DNA sequence 
whose expression changes the bacterial hosts’ phenotype is sandwiched between two insertion 
sequences arranged as direct or inverted repeats. The direct repeat arrangement is less 
genetically stable as compared to the inverted repeat, however, the direct repeats allow the 
transposon to migrate to other sites where the same IS element is found in a given genome 
(Bennett, 2008). Complex transposons on the other hand do not have transposing and non-
transposing functions assembled in an obvious arrangement (Bennett, 2008). 
 
In one surveillance study in Italy, 6.6 % of clonally related A. baumannii isolates harboured a 
TEM-92 extended spectrum -lactam gene (Endimiani et al., 2007). Tn3-like transposons are 
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linked to one such transposon (Endimiani et al., 2007). The isolates in this study were resistant to 
all -lactams tested, except the carbapenems.  
 
Transposon-related carbapenem resistance has been reported elsewhere (Poirel et al., 2008). 
The blaOXA-23 gene, linked to ISAba-1 in Tn2006 and to ISAba-4 in Tn2007 was identified in 
carbapenem-resistant A. baumannii isolates (Corvec et al., 2007). The Tn2006 structure had two 
inverted copies of ISAba-1 flanking the blaOXA-23 gene, together with a truncated ATPase gene. 
The transposon Tn2007 only had a single copy of ISAba-4. Interestingly, Tn2007 was associated 
with a partial ATPase-encoding gene downstream of the blaOXA-23 gene which was similar to the 
one flanking Tn2006. Further studies identified a truncated ATPase gene associated with blaOXA-
23 in carbapenem resistant A. baumannii isolates (Corvec et al., 2007). The ATPase gene may 
act as an insertion site for transposons (Corvec et al., 2007). 
 
Transposons and insertion sequences clearly play an important role, in conjunction with 
integrons, in ensuring that particular novel genes become established in a new gene pool. 
Should transposons be located on unstable plasmids in bacteria, the transposon could integrate 
and stabilise within the chromosome. Transposons are thus relevant for the dissemination of 
antibiotic resistance genes in Acinetobacter spp. (Devaud et al., 1982; Palmen & Hellingwerf, 
1997), either by integration in transferable plasmids or by direct integration within the bacterial 
chromosome. 
 
1.4.3. Insertion sequence elements 
Insertion sequence (IS) elements are small transposable genetic elements that range in size 
from 800 to 2500 bp and encode only those functions required for its transposition (Depardieu et 
al., 2007). Currently, over 1 000 IS elements have been identified in approximately 200 Gram-
negative and Gram-positive bacterial species and in archaea (Depardieu et al., 2007). IS 
elements are assigned to 17 families based on their structural and functional characteristics 
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classification of IS elements into various families is mostly a guideline as variations in 
characteristics of IS elements within the families are tolerable and uncertainties even exist in 
some of the families (Mahillon & Chandler, 1998).  
 
Table 1.2:  Major features of prokaryote IS families 
 
a Size range represents the typical range of each group. 
b Length of direct target repeats. Less frequently observed lengths are included in parentheses. 
c Conserved terminal base pairs. Capital letters (and capital letters within parentheses) refer to mostly (and often) conserved  
   bases. Lowercase letters separated by slashes indicate alternative conservation at that position. 
d Presence (Y) or absence (N) of terminal inverted repeats. 
e ORF, open reading frame. Number in parentheses indicates the possible involvement of a second ORF in the transposition  
   process. 
f DDE represents the common acidic triad presumed to be part of the active site of the transposase. ssDNA, single-stranded  
  DNA. 
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IS elements are typically bound by short repeat sequences of up to 40 bp in an indirect 
orientation. These IRs are specific for each element, and their presence and integrity are 
required for transposition, which may or may not be site specific (Grindley & Reed, 1985; Mahillon 
& Chandler, 1998; Depardieu et al., 2007). Repeat sequences of 2 to 14 bp, characteristic for 
each element, are generated in a direct orientation upon insertion of an IS element into the target 
DNA (Figure 1.4; Depardieu et al., 2007). Many IS elements carry a single ORF encoding a 
transposase. Some IS elements carry several ORFs on a single strand or on both strands, the 
products of which may also play a role in the regulation of the transposition process (Mahillon & 
Chandler, 1998; Chandler & Mahillon, 2002; Depardieu et al., 2007). Of particular interest, IS 
elements may contain partial or complete promoter sequences, often located at their extremities 
and in an outward orientation and capable of activating the expression of flanking genes 





Figure 1.4: Schematic representation of an IS element. IRL and IRR, inverted repeats; -35 and -35/-10, approximate 
locations of promoter consensus sequences. The direct repeats, DR, are not parts of insertion sequences but are 
generated within the host DNA upon the integration of an IS (Adapted from Grindley & Reed, 1985; Depardieu et al., 
2007). 
 
There is extraordinary variability in the distribution of the IS elements of the different families 
among bacterial species. For some IS families, e.g. IS21, the host range includes both Gram-
positive and Gram-negative genera (Yeo et al., 1998). For the IS3 family, the hosts are widely 
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Mahillon & Chandler, 1998). In some instances, IS elements are confined to a geographical area 
(Huh et al., 2004); IS1542, IS1251 and IS1476 are confined to UK/Ireland (Darini et al., 1999), 
United States of America (USA) and, Canada (Mackinnon et al., 1997) respectively. Some IS 
elements are restricted to few hosts, such as IS6110, which has been found only in mycobacteria 
of the tuberculosis complex (Thierry et al., 1990; Mahillon & Chandler, 1999). IS1 is unique to 
E. coli (Nymann et al., 1983) while IS1222 is found only in strains closely related to Enterobacter 
agglomerans (Steibl & Lewecke, 1995). IS1491 is common amongst pseudomonads (Yeo, et al., 
1998), IS2000 is unique to K. pneumoniae (Aubert et al., 2003), and ISAba-1 is thought to be 
unique to A. baumannii (Segal et al., 2005). 
IS elements may be present on the chromosome, plasmids, or both as si gle or multiple copies. 
Intercellular transfer is possible if the IS elements reside on conjugative plasmids (Depardieu et 
al., 2007). A number of factors account for the varied IS copy numbers in different bacterial 
genera; these include the transposition frequency of the IS element into the same strain 
(Nymann et al., 1983), and the genomic plasticity of the strains (Mahillon & Chandler, 1998). 
Most IS elements transpose readily, whilst others, such as IS200, rarely do so (Beuzón et al., 
2004). 
The involvement of IS elements in altered expression of resistance-conferring or resistance 
modulating genes, consisting in some cases of the activation of silent genes, has been 
suggested (Poirel & Nordmann, 2006a, 2006b; Depardieu et al., 2007; Munoz-Price & Weinstein, 
2008; Chen et al., 2008). The promoter regions in IS elements could be used by pathogens to 
over express antibiotic resistance genes. Such events have been described in the 
Enterobacteriaceae, strict aerobic and anaerobic Gram-negative bacteria, staphylococci, and 
enterococci (Depardieu et al., 2007), resulting in resistance to many classes of antibiotics. Thus, 
IS elements constitute a group of genetic elements that may effect multiple antibiotic resistance 
in clinical bacterial isolates. 
The expression of antibiotic resistance genes is a result of DNA polymerase binding to promoter 
sequences upstream of the gene to be expressed (Garret & Grisham, 2005). Insertion of an IS 
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IS-borne -35 region, or a completely new IS-borne promoter containing both the -35 and the -10 
regions (Figure 1.4). The canonical consensus sequence for the -35 and the -10 regions are 
TTGACA and TATAAT, respectively, with a 17 bp spacing distance for optimal promoter activity 
as determined for E. coli (Lisser & Margalit, 1993). 
The chromosomally encoded AmpC and OXA-51-like β-lactamases are intrinsic to A. baumannii 
(Munoz-Price & Weinstein, 2008). Usually, such β-lactamases have low expression levels that do 
not contribute to clinically significant resistance; however, the integration of ISAba-1 containing 
promoter sequences, upstream of ampC and of blaOXA-51 in A. baumannii increases β-lactamase 
production, resulting in limited treatment options for patients infected with these strains (Corvec 
et al., 2003; Segal et al., 2003; Poirel & Nordmann, 2006b). 
Hybrid promoters that result in increased expression of associated resistance genes have been 
reported (Poirel & Nordmann, 2006b; Chen et al., 2008). An ISAba-3-like element interrupted by 
a portion of IS1008 was integrated upstream of blaOXA-58 gene in an A. baumannii clinical isolate 
in Taiwan (Chen et al., 2008). The -10 promoter was located in the ISAba-3-like element while 
the -35 promoter, which conferred higher levels of expression, was in the IS1008 domain. In the 
presence of hybrid promoters; if nosocomial pathogens have the option to use those promoters 
conferring the strongest expression of resistance genes towards antibiotics, then the end of the 
antibiotic era may actually be reached sooner than expected. 
 
1.4.4. Integrons and gene cassettes 
Antibiotic resistance genes can be located within integron-borne cassettes, which provide a 
remarkably efficient means for mobilising various resistance genes (Stokes & Hall, 1989). 
Integrons are phylogenetically diverse and ancient, complex genetic elements, which have been 
implicated in dissemination of antibiotic resistant genes (Stokes & Hall, 1989; Gootz & Marra, 
2008; Labbate et al., 2009). They are capable of capturing genes by a site-specific recombination 
mechanism that often carries gene cassettes containing antibiotic resistance genes (Stokes & 
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gene (Hall et al., 1999; Rowe-Magnus et al., 2001). Class 1 integrons have a gene encoding an 
IntI1 integrase (Figure 1.5; Recchia & Hall, 1995). Class 2 integrons are related to Tn7-like 
transposons and have an intI2 gene that encodes an integrase with partial homology to IntI1 
(Young et al., 1994; Recchia & Hall, 1995). Class 3 integrons are associated with the integrase 
Int I3 that has 60.9 % homology with the IntI1 integrase (Arakawa et al., 1995). Class 4 integrons 
have a gene encoding an IntI9 integrase (Hochhut et al., 2001) that has 53 % homology to IntI2. 
Class 1 integrons are the most common in clinical isolates of Gram-negative bacteria (Levesque 
et al., 1995), including acinetobacters (Koeleman et al., 2001; Gombac et al., 2002; Severino & 
Magalhaes, 2004). Class 2 integrons have been identified in Acinetobacter species (Sallen et al., 
1995; Jones et al., 1997; Ploy et al., 2000; Koeleman et al., 2001) but are rare, and class 3 




Figure 1.5: Structure of an integron. Integrons are site-specific recombination elements that mediate the acquisition 
and spread of genes among bacterial populations. The 5’-CS contains an integrase gene (intI) followed by one 
primary attl recombination site (gray box). The 3’-CS is characterized by qacEΔ1, sul1, and two uncharacterised 
genes, orf5 and 6. Several cassettes, in this case aacC1, aadA1, and aacA4, can be inserted in no specific order 
between the two conserved regions. Each of the cassettes code for one gene and have one 59-be recombination 
site (white box).  The transcription of the system is controlled by a strong promoter (P) located upstream of the gene 
cassettes and associated with a weaker promoter (P2). This structure favours the arrangement of genes in tandem, 
which are transferred as single elements among bacterial populations (Adapted from Recchia & Hall, 1995; Martínez 
& Baquero, 2002, and Bonomo & Szabo, 2006). 
 
Class 1 integrons are marked by the presence of two conserved regions between which gene 
cassettes are integrated at a recombination site known as attI (Figure 1.5; Stokes & Hall, 1989; 
Recchia & Hall, 1995). The identities and number of the gene cassettes within a given integron 
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intI that encodes a site-specific recombination enzyme, integrase (Stokes & Hall, 1989; Hall & 
Collis, 1995).  
The 5'-CS also contains a promoter, P, and a second promoter, P2, which drive the expression of 
any integrated gene cassettes. Integrons have a truncated quaternary ammonium compound 
resistance gene qacEΔ1, a sul1 sulfonamide resistance gene, and two open reading frames 
(ORFs), ORF5 and ORF6, of unknown function (Hall & Collis, 1995).  
Gene cassettes are small, non-replicating, double stranded circular DNA molecules (Recchia & 
Hall, 1995). They encode antibiotic resistance genes and vary considerably in total length from 
262 to 1549 bp depending on the size of the gene, which covers most of the cassette length 
(Recchia & Hall, 1995; Figure 1.5). Their circular state is more of an intermediary stage as they 
get transferred between integrons or as they get reshuffled within a particular integron (Recchia 
& Hall, 1995). Gene cassettes lack promoters and are often found within integrons between the 
5'- and 3'- CSs (Recchia & Hall, 1995). Cassette integration occurs at the cassette integration 
site (attI) of the integron (Hall & Collis, 1995) or at non-specific sites within plasmids and 
chromosomes (Recchia & Hall, 1995; Segal & Elisha, 1997). Gene cassettes have a 
recombination site known as a 59-base element (59-be) that varies in size from 57 to 141 bp and 
is located at the 3'- end (Recchia & Hall, 1995; Toleman et al., 2006). The 59-be is a family of 
recombination sites that act as substrates to integrase-mediated recombination and is reformed 
whenever the gene cassette is excised from the integron (Recchia & Hall, 1995; Toleman et al., 
2006).  
The origin of the antibiotic resistance genes on cassettes is subject to speculation. The discovery 
of resistance gene families, like the dihydrofolate reductase B family, which were found only in 
combination with a 59-be, suggested a pool of antibiotic resistance genes different from the pool 
of resistance genes that are not linked to gene cassettes (Fluit & Schmitz, 1999). The ability of 
gene cassettes to integrate at secondary sites further complicates the tracing of the origin of the 
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Gene cassettes carry antibiotic resistance genes that encode activity against a wide range of 
antibiotics and antibiotic classes. Resistance to chloramphenicol is encoded either by one of 
seven gene cassettes encoding a chloramphenicol acetyltransferase or by one of the three 
known efflux pumps (Gootz & Marra, 2008). Resistance to rifampin and erythromycin encoded on 
gene cassettes has also been described (Houang, 2000). Most gene cassettes encode 
resistance to antibiotics that have been in use for a relatively long period of time. Notably, gene 
cassettes encoding resistance to β-lactams, including blaIMP, blaVIM, blaVEB-1, blaoxa15, blaoxa19, 
blaoxa20, and blaoxa21, have been described (Mugnier et al., 1998; Poirel et al., 1999; Laraki et al., 
1999; Lauretti et al., 1999; Poirel et al., 2000; Nordmann & Poirel, 2002). This indicates the 
important role played by cassettes in antibiotic resistance in A. baumannii and so causing great 
concern. 
Gene cassettes can be inserted one after the other, in different combinations (Hall & Stokes, 
1990; Stokes & Hall, 1991; Parent & Roy, 1992; Stokes et al., 1993; Naas et al., 1998), into the 
attI of integrons to produce impressive resistance gene arrays, such as the two copies of oxa2 in 
In1 (Stokes & Hall, 1992). It is because each cassette is inserted at the same point that the gene 
cassettes from the 5'-CS indicate the order of addition, the one nearest the 5'-CS being the latest 
addition (Bennett, 2008).  As many as five (Stokes & Hall, 1991; Stokes et al., 1993) to 30 
(Vaisvila et al., 2001) gene cassettes can be integrated into one integron. Various combinations 
of gene cassette in integrons play a vital role in the creation of new gene arrays, operons, or 
pathogenicity islands responsible for MDR A. baumannii strains. 
Integron–based antibiotic resistance has been frequently described in Enterobacteriaceae (Fluit 
& Schmitz, 1999) and clinical isolates of Pseudomonas spp. (Bunny et al., 1995; Kazama et al., 
1995).  Until the late 1990s, descriptions of integrons in Acinetobacter were rare (Gonzalez et al., 
1998; Seward & Towner, 1998; Petersen et al., 2000; Ploy et al., 2000; Gallego & Towner, 2001). 
The first report on the presence of integrons in isolates of A. baumannii was in Chile (Gonzalez 
et al., 1998). Various studies have described antibiotic resistance genes located on integrons in 
Acinetobacter species (Seward et al., 1998; Ploy et al., 2000; Gallego & Towner, 2001; Gombac 
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Although class 1 integrons are the most prevalent in clinical isolates of antibiotic resistant Gram-
negative bacteria (Rowe-Magnus et al., 2001). Surprisingly, class 2 integrons were more 
frequent in A. baumannii biotype 9 isolates (Sallen et al., 1995; Jones et al., 1997). These 
isolates were previously known to exhibit higher levels of resistance as well as broader 
resistance patterns to β-lactams, sulfonamides, trimethoprim, tetracycline, chloramphenicol, and 
aminoglycosides (Sallen et al., 1995; K.E. Sossa, personal communication in Gonzalez et al., 
1998).  
 
Although many variants of acquired bla genes are detectable in A. baumannii, some metallo-β-
lactamase variants are not commonly found in this bacterium (Gootz & Marra, 2008). Three 
imipenem-resistant A. baumannii clones with blaVIM alleles on class 1 integrons were identified in 
a study conducted in Greece (Tsakris et al., 2008). One of the clones harbored a blaVIM-4 allele; a 
point mutant of the blaVIM-1 variant which was first identified in a carbapenem-resistant 
P. aeruginosa clinical isolate (Pournaras et al., 2002). This variant has now been detected in 
numerous P. aeruginosa clones in Greece (Pournaras et al., 2003), and in pseudomonads and 
enterobacteria in several other European countries, Australia and Tunisia (Luzzaro et al., 2004; 
Ktari et al., 2006; Libisch et al.,  2006).  
 
Extended spectrum β-lactamases have rarely been identified in A. baumannii (Perez et al., 2007; 
Gootz & Marra, 2008). In 2002, a blaCTX-M-2 gene was identified in an A. baumannii nosocomial 
isolate (Arduino et al., 2002) on an integron, In35. The integron, In35, also had blaOXA-23 and 
aac(6’)-Ib gene cassettes, and partial gene sequences of sul1 and qacEL, a metal efflux pump 
gene. Identification of In35 in Proteus mirabilis, K. pneumoniae, Enterobacter cloacae, 
S. marcescens and Salmonella spp. recovered from the same hospital as the A. baumannii 
isolate suggested interspecies transfer of this genetic element (Arduino et al., 2002).  
 
In one study, strains of A. baumannii that had infected multiple patients in one hospital contained 
significantly more integrons in their genomes than those that had only infected single patients 
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antibiotic-resistant isolates containing more integrons were more fit for hospital infection than 
non-integron-containing isolates (Koeleman et al., 2001). 
 
Although integrons are immobile, they are sometimes found as part of transposons or plasmids, 
through which they can be transferred between different pathogens. Class 1 integrons can be 
found in Tn21 and Tn21-related transposons (Schmidt et al., 1989; Parent & Roy, 1992; 
Sundstrom et al., 1993). Plasmids and chromosomal DNA thus, represent platforms on which 
gene arrays are assembled and reassorted (Schmidt et al., 1989) in which the latter may result in 
the formation of pathogenicity islands.  
 
1.4.5. Pathogenicity islands 
In some pathogens, foreign DNA, in the form of IS elements, gene cassettes, transposons and 
integrons, is assembled in one area of the organisms’ chromosome or plasmids to form 
pathogenicity islands (PAIs). These islands represent distinct clusters of virulence genes, which 
are outcomes of horizontal gene transfer, (Smith et al., 2007) and they extend the range of 
habitats that can be colonised by bacterial species.  Genes located within PAIs have been used 
as diagnostic markers for pathogen identification in clinical specimens and for the differentiation 
of pathogenic strains from closely related non-pathogenic strains (Schmidt & Hensel, 2004). 
Toxins encoded by genes on PAIs can be used as tools in cell biology (Schiavo & van der Goot, 
2001). Protein secretion systems, often found in PAIs, can be used to deliver heterologous 
antigens for vacci ation strategies with live carrier strains (Rüssmann et al.1998; Gentschev et 
al. 2002). PAI-encoded virulence determinants, such as secretion systems, may be targets for 
novel forms of therapeutic intervention of bacterial infections. 
PAIs are a sub-group of genomic islands sharing a set of unifying features (Hentschel and 
Hacker, 2001). These features include i) the carriage of one or more virulence genes; ii) their 
presence in the genomes of pathogenic bacteria but not in the genomes of a non-pathogenic 
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size ranging from 10 to 200 kb;  iv) a different G + C content to that of the core genome, as well 
as different codon usage;  v) an association with tRNA genes or, as in A. baumannii, within 
ATPase genes (Fournier et al., 2006; Shaikh et al., 2009; Post & Hall, 2009);  vi)  the association 
with mobile genetic elements and mobility genes, often flanked by direct repeats; and vii) a more 
mosaic-like structure rather than homogeneous segments of horizontally acquired DNA (Schmidt 
& Hensel, 2004). 
 
PAIs have been identified in various pathogenic bacteria. The 40 kb cag PAI in Helicobacter 
pylori contributes to the pathogen’s virulence by encoding type IV secretion system genes. Type 
IV secretion systems play a role in host cell invasion, inactivation of phagocytic cells, apoptosis, 
and interference with intracellular transport processes (Censini et al., 1996). P. aeruginosa strain 
PAO1 has a 50 kb PAI, PAG1, consisting of 51 ORFs, most of which encode dehydrogenases 
and paraquat-inducible proteins involved in redox recycling and detoxification (Stover et al., 
2000;  Larbig et al., 2003). PAG1 thus plays an important role in protecting strain PAO1 against 
oxidative damage (Liang et al., 2001; Schmidt & Hensel, 2004; Yoon et al., 2005).  
Recently, PAIs were described in strains of A. baumannii (Fournier et al., 2006; Smith et al., 
2007; Iacono et al., 2008). An 86 kb resistance island (AbaR1) carrying 45 resistance genes 
acquired by horizontal gene transfer from various Gram-negative species was identified in 
A. baumannii strain AYE (Fournier et al., 2006).  Strain AYE is resistant to several β-lactams, 
aminoglycosides, fluoroquinolones, chloramphenicol, tetracycline, and rifampin (Smith et al., 
2007).  AbaR1 was also inserted into an ATPase gene that did not have any resistance genes in 
the antibiotic-susceptible strain A. baumannii SDF. This highlights the exceptional ability of 
A. baumannii to gather and assemble foreign genes (Fournier et al., 2006). A further PAI, AbaR2, 
was identified in a multi-drug resistant A. baumannii strain ACICU (Iacono et al., 2008). AbaR2 is 
smaller and only carries seven resistance genes. The gene cassette array identified in a class 1 
integron located on both AbaR1 and AbaR2 is completely different despite identical genes 
flanking the 5  and 3  conserved regions. The presence of these related resistance islands in 
AYE and ACICU suggests that AbaR1 and AbaR2 may originate from an island in a common 
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In another study, antibiotic resistance genes were located on seven of 28 putative alien islands 
identified in A. baumannii ATCC 17978 as determined by high density pyrosequencing and 
transposon mutagenesis (Smith et al., 2007). Strain ATCC 17978 is resistant to β-lactams 
however, it shows weak resistance to tetracycline and it is aminoglycoside (kanamycin) sensitive 
(M.G. Smith & M. Snyder, unpubl. in Smith et al., 2007). The presence of seven antibiotic-
resistance islands is surprising, especially since this strain was isolated in or around 1951 
(Baumann, 1968), prior to the development of the macrolides (erythromycin), glycopeptides 
(vancomycin), and cephalosporins and other latter generations of β-lactams.  
 
There are examples of highly mobile PAIs that can be converted into phages or plasmids and 
these include VSP-2, VSP-I and VSP-II of Vibrio cholera (Jermyn & Boyd, 2002; O'Shea & Boyd, 
2002; Rajanna et al., 2003; Jermyn & Boyd, 2005; Murphy & Boyd, 2008). Between highly mobile 
PAIs and those stably integrated within the host genome, various intermediate forms of PAIs can 
be found (Murphy & Boyd, 2008). Some gene clusters can be found on both PAIs and plasmids, 
indicating that the corresponding PAI carries an integrated plasmid. It would be interesting to 
determine any such mobile PAIs in A. baumannii.  
With so much genetic exchange within A. baumannii and between A. baumannii and other 
genera, it would be interesting to determine the transcriptional regulation mechanisms of 
antibiotic resistance genes. 
 
1.5 Transcriptional regulation of antibiotic resistance genes in Acinetobacter baumannii 
A complex multimeric RNA polymerase regulates transcription in E. coli. The subunits of the RNA 
polymerase, α, β, and β′ all have their specific roles in transcription. A sigma factor, δ, allows the 
core polymerase (α2ββ′) to recognise different promoter sequences (Garret & Grisham, 2005). In 
E. coli, the crucial step of initiation of mRNA synthesis is strongly influenced by the sequence of 
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TTGACA and TATAAT respectively, optimally separated by 17 bp for E. coli. The closer 
sequences are to the consensus sequences, the stronger the promoter (Garret & Grisham, 
2005). The first two bases of the hexamers are known to be the best conserved ones among the 
various promoters sequenced (Harley & Reynolds, 1987).  
In 1997, an aadB cassette from A. baumannii strain SUN was identified within a secondary site 
on plasmid pRAY (Segal & Elisha, 1997). The cassette was regulated by promoter sequences 
different from those used by E. coli (Segal & Elisha 1999). In 2003, putative –35 and –10 boxes 
(TTGTTC and TATGAT) separated by 17 bp were detected in a mobile element about 100 bp 
upstream of the start codon in the A. baumannii ampC gene (Corvec et al., 2003). These 
promoter sequences also differed from the E. coli consensus sequences by three bases and one 
base, respectively, the first bases being conserved. A. baumannii thus, recognises similar and 
not necessarily identical promoter sequences from E. coli (Segal & Elisha, 1997; Segal & Elisha, 
1999). The aminoglycoside resistance genes aac(6’)-Ig and aac(6’)-Ij in A. haemolyticus and 
Acinetobacter sp. 13 have promoter sequences similar to Eδ70 in E. coli, however, they are 
separated by 21 and 15 bp respectively (Lambert et al., 1993). This unusual spacing has also 
been recognised in the promoter sequences of the genes involved in tryptophan synthesis in 
A. calcoaceticus (Haspel et al., 1990), esterase biosynthesis in A. calcoaceticus (Kok et al., 
1995), and in aac(6’)-Ig (Lambert et al.,1993),  blaOXA-27 (Segal et al., 2003), and ampC (Segal et 
al., 2004, Corvec et al., 2003) expression in A. baumannii. Interestingly, a promoter located in 
ISAba-1, upstream of a blaOXA-23 gene, expressed the blaOXA-23 gene in E.coli more readily than it 
did in A. baumannii (Segal et al., 2007), even though ISAba-1 may be specific to Acinetobacter 
spp. (Segal et al., 2005). 
 
1.6 Aims of this study 
Since the treatment options for MDR A. baumannii infections are generally limited to 
carbapenems, the emergence of imipenem and meropenem resistance is a growing cause for 
concern (Rice, 2006). A. baumannii acquires most resistance genes on mobile genetic elements 
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Some mobile genetic elements, like ISAba-1, enable increased expression of resistance genes 
by providing preferred promoter sequences (Corvec et al., 2003; Segal et al., 2005), and may be 
responsible for the plasticity observed in the A. baumannii genome (Segal et al., 2005). The role 
of these mobile genetic elements in the spread, maintenance and expression of antibiotic 
resistance genes in A. baumannii is of great interest. 
 
In 2005, a carbapenem susceptible Acinetobacter isolate, MOS1, was obtained from a patient at 
GSH, Cape Town. The patient was treated with meropenem. Two weeks later, another 
A. baumannii isolate, MOS2, was obtained from the same patient. MOS2 was carbapenem 
resistant. It may be that MOS2 arose due to MOS1 acquiring a carbapenem resistance gene 
following antibiotic selective pressure, or that the patient harboured both MOS1 and MOS2, and 
following carbapenem treatment, the resistant MOS2 was selected for.  
 
Strain MOS1 has a genetic arrangement in which an aminoglycoside resistance gene, aacC2a, is 
linked to IS1133 interrupted by a full copy of ISAba-1 (Figure 1.6; Segal et al., 2003; Jacobson, 
2007). This genetic arrangement has been conserved for more than 20 years in A. baumannii 
clinical isolates in Cape Town, South Africa (Elisha & Steyn, 1991; Jacobson, 2007). The T to A 
transversion within the IS1133 right inverted repeat is believed to have stabilized this genetic 
arrangement in A. baumannii at least since 1983. 
 
 
Figure 1.6: Genetic arrangement of the aminoglycoside resistance gene, aacC2a (yellow), downstream of a portion 
of IS1133 (red). IS1133 is interrupted by a full copy of ISAba-1 (purple) in strain MOS1. This genetic arrangement 
has been conserved for over 20 years in A. baumannii isolates obtained from patients at GSH and Red Cross War  
Memorial children’s hospital. The arrows indicate direction of transcription.  The shaded regions represent inverted 
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Following PFGE genotyping of A. baumannii isolates collected over a 23 year period, it is 
interesting to note that all isolates that harbour the aacC2a gene have the same PFGE profile 
(Jacobson, 2007). Included in that group of isolates was MOS1. MOS2, however has a different 
PFGE profile, is resistant to carbapenems, and carries an ISAba-1-linked blaOXA-23 gene, 
suggesting that these two strains are genetically distinct. This also suggests that the patient from 
which MOS1 and MOS2 were isolated, was co-infected with these two strains, and that following 
antibiotic treatment, MOS2 was selected for. 
 
It may be that when MOS1 and MOS2 originally diverged, the aacC2a-associated conserved 
region in MOS1-like strains, as part of a larger mobile genetic element, was replaced via 
horizontal gene transfer by a genetic arrangement containing the ISAba-1-linked blaOXA-23 gene 
to give rise to MOS2-related strains. Sequences flanking the IS1133L/ISAba-1/IS1133R-aacC2a 
genetic arrangement may give further insight into the origin and role of these genetic 
arrangements in A. baumannii MOS1 and MOS2. 
 
The aims of this study are thus: 
i. To screen for the presence of large mobile genetic elements 
ii. To characterize further sequences associated with the IS1133L/ISAba-1/IS1133R-
aacC2a conserved genetic arrangement in MOS1 
iii. To determine the role of the mobile genetic elements associated with this conserved 
region in MOS1 
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2.1 Bacterial strains and antibiotic susceptibility testing 
A. baumannii strains MOS1 was obtained from a patient admitted to GSH, Cape Town, South 
Africa, in 2005. Following two weeks of meropenem treatment, strain MOS2 was obtained from 
the same patient. Selected carbapenem resistant and susceptible isolates obtained from 1983 to 
2008 from patients at GSH and Red Cross War Memorial Children’s Hospital, Cape Town, were 
also included in this study.  
The antibiotic susceptibility profiles are indicated in Table 2.1. Susceptibility testing with selected 
antibiotics was carried out using the disc diffusion method in the National Health Laboratory 
Service laboratory, GSH, according to the guidelines of the National Committee for Clinical 
Laboratory Standards.  
Escherichia coli JM109 (Promega, USA) was used as the recipient in transformation studies 
(2.5). 
A selection of isolates including A. lwoffii, A. calcoaceticus, P. aeruginosa, Campylobacter 
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Table 2.1. Antibiotic susceptibility profiles of A. baumannii isolates included in this study 
Bacterial isolate Antibiotic resistance profile Year obtained 
MOS1 Gm, Amik, Cipro, SXT 2005 
MOS2 Gm, Amik, Cipro, SXT, IMP, MPM 2005 
794 Gm, Amik, Cipro, SXT, IMP, MPM 2008 
A2 Gm, Cipro, SXT, IMP, MPM 2006 
A3 Gm, Amik, IMP, MPM, Tob 2006 
A4 Gm, Amik, Cipro, SXT, IMP, MPM, Tob 2006 
A5 Gm, Amik, Cipro, SXT, IMP, MPM, Tob 2006 
A7 Gm, Amik,  IMP, MPM, Tob 2006 
A9 Gm, Amik, Cipro, SXT, IMP, MPM 2006 
A10 Gm, Cipro, SXT, IMP, MPM 2006 
A19 Gm, Amik, Cipro, SXT, IMP, MPM, Tob 2006 
A21 Amik 2006 
A40 Gm, Cipro, SXT, IMP, MPM 2006 
A91 Gm, Amik, Cipro, SXT, IMP, MPM 2006 
Gm, Gentamicin; Amik, Amikacin; Cipro, Ciprofloxacin; SXT, Cotrimoxazole;  
 







Table 2.2. Bacterial isolates used to screen for mobile genetic elements 
 Organism Isolates included 
E. coli JE1, JE2, LK111, MTH 
P. aeruginosa P5, P26, P28, PACT1, PACT2, PACT3, PACT4, PACT7 
K. pneumoniae 795, JK1, JK2, K1, KAT 
C.  jejuni 390 
A. lwoffii 2, 3 
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2.2 DNA extraction 
2.2.1 Genomic DNA extraction  
Genomic DNA was obtained using the phenol/ chloroform method (Ausubel et al., 1987). Frozen 
cultures of MOS1 and MOS2 bacterial strains were streaked onto two times Yeast-Tryptone (2 x 
YT) agar (Appendix A) plates. A single colony of each strain was inoculated into 5 ml 2 x YT 
broth (Appendix A), without antibiotic selection, and incubated to saturation at 37oC overnight 
with shaking. A 2 ml aliquot of the culture was centrifuged in an Eppendorf centrifuge 5417C 
(Germany) and the pellet resuspended in TE buffer (Appendix A). Bacterial cell lysis was 
enhanced by using 0.5 % (v/v) of the detergent sodium dodecyl sulphate (SDS). Cellular proteins 
were removed by digestion with 100 g/ml of the non-specific protease, proteinase K (Merck, 
Germany), for an hour at 37oC.   
To remove cell wall debris, denatured protein, and polysaccharides, selective precipitation with 
cetyltrimethylammonium bromide (CTAB) was used. A chloroform/isoamyl alcohol (24:1) mixture 
was added and centrifuged to extract CTAB-protein/polysaccharide complexes, leaving nucleic 
acids in solution. Genomic DNA was precipitated using 0.6 volumes isopropanol and the pellet 
was washed with 70 % ethanol before drying in a fume hood for 5-10 minutes and resuspending 
in 100 μl TE buffer. The quality of the DNA was confirmed by electrophoresis on a 1 % (w/v) 
agarose gel (2.3.2) and by using it as a template in a polymerase chain reaction (PCR) (2.6). 
DNA was quantified by using a Nanodrop spectrophotometer, ND-1000 UV/Vis (USA). DNA was 
stored at 4oC until required.  
When screening recombinant clones, ten recombinant colonies were resuspended in 20 μl 
distilled water. After boiling for ten minutes and rapidly cooling on ice to prevent any nucleases 
degrading the released DNA, the sample was centrifuged briefly. A 2 μl aliquot of the supernatant 
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2.2.2 Small-scale plasmid DNA extraction 
The vector pUC19 (Appendix B) was used for cloning in this study. Plasmid DNA was extracted 
according to the manufacturer’s instructions, using a Miniprep spin kit (Qiagen, Germany). E. coli 
JM109 contaning pUC19 was streaked onto LB agar (Appendix A) plates containing 100 mg/ml 
ampicillin (Bodene, South Africa), 40 mg/ml 5-bromo-4chloro-3indolyl-β-D-galactosidase (X-gal, 
Roche, Germany), and 4 mg/ml isopropyl-β-D-thio-galactosidase (IPTG, Roche, Germany). A 
single blue colony was selected and inoculated into 5 ml LB broth (Appendix A) containing 100 
mg/ml ampicillin and incubated at 37oC overnight with shaking.  The cell mass was precipitated 
in a 1.5 ml eppendorf tube by centrifugation and the pellet resuspended in Buffer P1 containing 
100 μg/ml RNaseA, 10 mM EDTA, and 50 mM Tris.Cl.  The cells were lysed using SDS (1 %; 
w/v)-containing Buffer P2. The NaOH (200 mM) in Buffer P2 causes cellular proteins, 
chromosomal, and plasmid DNA to denature. The lysate was finally neutralised with Buffer N3 to 
recover the plasmid. The high salt concentration in Buffer N3 (3 M potassium acetate) causes the 
denatured macromolecular structures to precipitate. Following centrifugation, the supernatants 
were transferred to a QIAprep spin column and cleaned by successive washes with Buffer PB 
and Buffer PE.  Plasmid DNA was eluted by adding 50 μl Buffer EB, allowing this to stand at 
room temperature for a minute and then centrifuging at 13 000 rpm for one minute.  
Plasmid DNA was quantified by comparison to known concentrations of the molecular weight 
marker, HyperLadder I™ (Bioline, UK, Appendix C) and by using a Nanodrop spectrophotometer, 
ND-1000 UV/Vis (USA).  The quality of plasmid DNA was confirmed by restriction enzyme 
digestion (2.3.1) followed by electrophoresis on a 1 % (w/v) agarose gel (2.3.2).  DNA was stored 
at 4oC until required.  
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2.2.3 Large-scale plasmid DNA extraction 
Plasmids were extracted using a Midiprep spin kit (Qiagen, Germany) where necessary 
according to manufacturer’s instructions. A single blue colony was picked from a freshly streaked 
selective plate containing 100 mg/ml ampicillin, 40 mg/ml X-gal and 4 mg/ml IPTG. The colony 
was inoculated into a starter culture of 5 ml LB broth containing 100 mg/ml ampicillin and 
incubated at 37oC for 8 hours with shaking.  The starter culture was diluted 1/500 - 1/1000 in a 
total volume of 50 ml and incubated for 12-16 hours at 37oC with shaking.  Bacterial cells were 
harvested by centrifugation at 6000 rpm for 15 minutes at 4oC and resuspended in 6 ml Buffer P1 
with RNase A (100 μg/ml; Roche, Germany) added to it. Subsequently, 60 ml of P2 lysis buffer 
and 6 ml chilled Buffer P3 were added to the mixture. The lysate was immediately transferred to 
the barrel of a QIAfilter cartridge, incubated at room temperature for 10 minutes for optimal 
performance and filtered into a HiSpeed Midi Tip previously equilibrated with Buffer QBT. The 
HiSpeed Midi Tip was washed with 20 ml Buffer QC. Plasmid DNA was eluted with 5 ml Buffer 
QF in a clean receiver tube and precipitated with 3.5 ml isopropanol. This was mixed and allowed 
to stand for 5 minutes. The plasmid DNA was then bound to a QIAprecipitator using a syringe, 
washed with 70 % ethanol, and eluted with 0.5 ml Buffer TE into a clean microcentrifuge tube. 
Plasmid DNA was quantified by comparison to known concentrations of the molecular weight 
marker, HyperLadder I™ (Bioline, UK, Appendix C) and by using a Nanodrop spectrophotometer, 
ND-1000 UV/Vis (USA).  The quality of plasmid DNA was confirmed by restriction enzyme 
digestion (2.3.1) followed by electrophoresis on a 1 % (w/v) agarose gel (2.3.2).  DNA was stored 
at 4oC until required.  
 
2.3 DNA analysis and purification 
2.3.1 Restriction enzyme digestion 
Genomic DNA (5 μg) and pUC19 (2 μg) were digested with 10 U of EcoRI (Roche, Germany) 
and 10 U of HindIII (Roche, Germany) or 10 U of BamHI (Roche, Germany) in a total volume of 
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at 37oC for 3 hours.  Double, instead of single digests, were performed to reduce the chances of 
the cloning vector, pUC19, recombining to itself during ligation (2.4). Religated pUC19 can be 
transformed into E. coli JM109 competent cells and this reduces the chance of obtaining 
recombinant clones. The restriction enzyme EcoRI recognises the sequence G↓AATTC, HindIII 
recognises A↓AGCTT, and BamHI recognises G↓GATCC. All the enzymes therefore produce 
overhangs following restriction digestion. Using two enzymes to digest pUC19 results in a linear 
plasmid with a different restriction site on either end, thus preventing pUC19 from religating. 
Double digests ensured genomic DNA fragments of smaller molecular size, rather than larger 
fragments produced using only one enzyme. This was done to increase the religation of 
fragments into pUC19, which is known to not readily take up larger DNA fragments 
(Brown, 2003). The efficiency of the digestion was confirmed on a 1 % agarose gel (2.3.2).  
 
2.3.2 Agarose gel electrophoresis 
Agarose gel electrophoresis resolves DNA fragments on the basis of their differing rates of 
migration, which in turn are dependent on their size. Since DNA carries a negative electric 
charge due to the phosphate groups on its sugar-phosphate backbone (Brown, 2003; Garrett & 
Grisham, 2005), it will migrate towards the positive electrode in the presence of an electric 
current. Smaller fragments migrate faster than larger ones as they pass through the agarose gel 
pores with more ease. In this study, DNA was resolved on horizontal gels of 1 or 2 % (w/v) 
agarose (Lonza, USA) dissolved in 1 X TAE buffer (Appendix A). The agarose was dissolved by 
heating the solution in a microwave oven and then allowed to cool. Ethidium bromide (EtBr, 
Fluka, Switzerland) was added at a final concentration of 10 ng/μl, and the gel poured into a 
mould of the appropriate size with a comb at one end. Once the gel had set, the comb was 
removed and the gel submerged in 1 X TAE buffer in an electrophoresis tank. EtBr is a 
fluorescent dye that intercalates between the adjacent base pairs of DNA. The fluorescent yield 
of EtBr-DNA complexes is greater than that of unbound dye. EtBr absorbs ultraviolet (UV) light at 
302 nm (Sambrook et al., 1989). DNA was thus visualized at 302 nm by UV transillumination 
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DNA samples were loaded with 5 X loading buffer (Bioline, UK) containing sucrose, bromophenol 
blue and ethylenediaminetetra-acetic acid (EDTA). Sucrose increases the samples density, 
ensuring that the DNA remains in the well and migrates evenly. Bromophenol blue allows one to 
monitor the rate of migration of the DNA samples, and EDTA chelates Mg2+ ions thereby 
inhibiting enzymatic activity that may degrade the DNA. 
The molecular weight marker HyperLadder I™ or IV™ (Bioline, UK, Appendix C) was loaded 
alongside DNA samples in 1 or 2 % agarose gels, respectively. The markers are both molecular 
weight and quantitative markers. Each band corresponds to a specific size and known DNA 
concentration. The size and the approximate concentration of the DNA samples could thus be 
determined.  
Electrophoresis was performed at 90 volts for 1-2 hours depending on the size of the gel.  
 
 2.3.3 Agarose gel extraction of DNA 
DNA was electrophoresed and excised from agarose gels using a MiniElute gel extraction kit 
(Qiagen, Germany) according to the manufacturer’s instructions. Three volumes of QG buffer 
were added to one volume of the excised gel fragment.  Following 10 minutes of incubation at 
50oC, one gel volume of isopropanol was added and mixed by inverting several times to help 
precipitate the DNA. The solution was transferred to a MiniElute column and centrifuged for 1 
minute, allowing the plasmid to bind to the matrix. The flow through was discarded, 500 μl QG 
buffer was added to the column and centrifuged for another minute. The column was washed 
with 750 μl buffer PE and residual ethanol was removed by an additional centrifugation step for a 
minute. The DNA was eluted with 10 μl purified distilled water dropped onto the centre of the 
column membrane and allowing it to stand at room temperature for a minute. Following 
centrifugation, the eluant was collected and stored at -20oC to prevent it from degradation in the 
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2.3.4 Genomic DNA precipitation 
Digested genomic DNA was recovered using the ethanol precipitation method by Ausubel and 
colleagues (1987). The digested sample was made up to 100 μl with purified distilled water.  
Sodium acetate at 3 M and 300 μl 100 % ethanol were added to the solution and incubated at -
70oC for an hour. DNA was precipitated, washed with 1 ml 70 % ethanol and air dried for 5-
10 minutes. The DNA was resuspended in 10 μl distilled water at room temperature for an hour. 
DNA was stored at -20oC to prevent it from degradation in the absence of buffering and chelating 
agents. 
 
2.4 DNA ligation 
Digested A. baumannii MOS1 genomic DNA (2-5 μg; 2.3.1) was ligated to 50-100 ng similarly 
digested pUC19. The final reaction volume of 10 μl also contained 1 U T4 DNA ligase (Roche, 
Germany) in 1 X buffer. The ligation reaction proceeded overnight at 4oC. 
 
2.5 Transformation of E. coli JM109 cells 
Transformation was performed using E. coli JM109 competent cells (Promega, USA) following 
the manufacturer’s instructions. The competent cells were placed on ice until just thawed after 
which an aliquot of the ligation reaction was added. The mixture was incubated for 30 minutes on 
ice to decrease the membrane potential of the cells (Panja et al., 2006) in preparation for the 
next step. To allow the uptake of recombinant plasmids, the mixture was heat shocked for 
45 seconds in a 42oC water bath after. The tubes were immediately placed on ice for two 
minutes to maintain the transformed plasmid within the competent cells. This was achieved by 
increasing the membrane potential of the competent cells (Panja et al., 2006). The 
transformation reaction was made up to 1 ml with SOC medium (Appendix A) and incubated at 
37oC for one hour with shaking to allow for the expression of the amp gene. A 100 μl aliquot was 
diluted 1:10 with SOC medium, and 100 μl aliquots of both the diluted and undiluted cultures 
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The cloning vector pUC19 harbours an ampicillin resistance gene, hence the selection of 
transformants on ampicillin-containing agar. X-gal was included as a colour indicator of β-
galactosidase activity, which is induced by IPTG. pUC19 carries a lacZ' gene that encodes the 
amino terminal (α-peptide) of the enzyme β-galactosidase (Brown, 2003). When pUC19 is 
introduced into bacteria containing the carboxyl terminal (ω-peptide) of β-galactosidase, e.g. 
E. coli JM109, the bacterial and plasmid components of the protein complement each other (α- 
complementation) to produce a functional enzyme. X-gal is hydrolised by β-galactosidase to give 
a non-diffusable blue dye, resulting in blue colonies on media with X-gal. If the α-peptide 
sequence in pUC19 is interrupted by cloning in the multiple cloning site (Appendix B), α- 
complementation cannot take place and colonies will appear white. Thus, putative recombinants 
will appear as white colonies on agar plates with ampicillin, X-gal and IPTG, and these were 
subcultured onto 2 x YT agar plates with 100 mg/ml ampicillin. The plates were incubated over 
night at 37oC.  
 
2.6 Polymerase chain reaction  
The polymerase chain reaction (PCR) is a primer-directed enzymatic reaction that results in the 
selective amplification of a chosen region of a DNA molecule (Figure 2.1).  Any region of DNA 
can be amplified, given that sequences at the boarders of the required region are known.  Two 
short oligonucleotides, known as primers, must hybridize to the DNA molecule, one on each 
strand of the double helix. The primers, thus, restrict the region that will be amplified. 
Amplification is carried out by a thermo-stable DNA polymerase I enzyme from the bacterium 
Thermus aquaticus (Taq polymerase; Saiki et al., 1988). The reaction conditions (Table 2.3) 
involve an initial denaturation step at 95oC for 5 minutes, followed by multiple cycles of DNA 
denaturation at 95oC for 45 seconds to five minutes, annealing of primers at 42 to 65oC for 
30 seconds to a minute, and DNA extension by the polymerase at 72oC for one minute per kb of 
target DNA. A final extension step at 72oC for 5 minutes completes the reaction. Thermostable 
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The reaction components consisted of 25 mM MgCl2, unless specified, 2.5 mM each dNTP, 20 
pmoles forward and reverse primer each and 2.5 U GoTaq Flexi DNA Polymerase (Promega, 
USA) in the appropriate buffer, made up to 50 μl with distilled water. Typically, 10-100 ng of DNA 
(2.2) was added as template. A negative control with no DNA was included to detect possible 
contamination of any of the reagents. PCR was carried out in a GeneAmp® PCR system 2 700 




Figure 2.1: Diagrammatic representation of the polymerase chain reaction (PCR). (Taken from 
http://users.ugent.be/~avierstr/principles/pcrcopies.gif) 
 
Primers were designed using DNAMAN software (Version 4.0, Lynnon Biosoft) and synthesised 
in the Molecular and Cell Biology Department, University of Cape Town. The oligomers were 
synthesized using a Polygen DNA synthesizer (Germany) with the standard procedure and 
purification. They were stored at 50 mM in Milli-Q water at -20oC. Primers used in this study are 
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Primer sequence     (5 '       3') *PCR cycle (X 35) product 
size (bp) 
ATPase gene a42-156F ATT GAT GTA CCG  CCA TTA 95
oC (1 ) 58oC (45 ) 72oC (45 ) 253 
 a46-358R GTG AAC CAT CTT TGG GCA   
     
ATPase gene linked 
to IS26 a42-156F ATT GAT GTA CCG  CCA TTA 
95oC (1 ) 58oC (45 ) 72oC (4 ) 
≥ 2 175 
 bIS26F2 TCA CTC CAC GAT TTA CC   
     
 bIS26F2 TCA CTC CAC GAT TTA CC 95
oC (1 ) 58oC (45 ) 72oC (4 ) ≥ 2 175 
 a 46-358R GTG AAC CAT CTT TGG GCA   
     
ATPase gene linked 
to IS1133 a42-156F ATT GAT GTA CCG  CCA TTA 
95oC (1 ) 58oC (45 ) 72oC (4 ) 
≥ 967 
 cIS1133F5 GAT GTT TGA GCA GTA GC   
     
 cIS1133F5 GAT GTT TGA GCA GTA GC 95
oC (1 ) 58oC (45 ) 72oC (4 ) ≥ 967 
 a46-358R GTG AAC CAT CTT TGG GCA   
      
aacC2a  caacC2aF CGC GGA AGG CAA TAA C 95
oC (1 ) 51oC (45 ) 72oC (1 ) 786 
 caacC2aR GCT TCT CAA GAT AGG TG   
     
Sequences upstream  d M13R CAG GAA ACA GCT ATG AC 95oC (1 ) 58oC (45 ) 72oC (4 ) ≥ 1 014 
of IS1133 c IS1133F5 GAT GTT TGA GCA GTA GC   
     
IS1133  cIS1133F2 GTT CCG GTC TTT TTG AG 95
oC (45 ) 52oC (45 ) 72oC (1 ) 949 
 cIS1133F5 GAT GTT TGA GCA GTA GC   
     
ISKpn12  bISKpn12F CTT CAG CCC TAT TTC CC 95
oC (1 ) 60oC (45 ) 72oC (45 ) 735 
 bISKpn12R3 GGT CAG GAC TCA TTG CT   
     
 bISKpn12F CTT CAG CCC TAT TTC CC 95
oC (1 ) 56oC (45 ) 72oC (45 ) 704 
 bISKpn12R2 AAC GGT CGC AGC GAG AG   
     
 bISKpn12F2 TTC ATA ACG GCA GGC CA 95
oC (1 ) 52oC (45 ) 72oC (45 ) 321 
 bISKpn12R2 AAC GGT CGC AGC GAG AG   
     
ISKpn12 tnpA bISKpn12F CTT CAG CCC TAT TTC CC 95
oC (1 ) 52oC (45 ) 72oC (45 ) 230 
 bISKpn12R GCA GAG CAC AAG ACC AT   
     
16 S rRNA  c16SF ACC ACA GTC CAT GCC ATC AC 95
oC (45 ) 50oC (45 ) 72oC (1 ) 449  
 c16SR TCC ACC ACC CTG TTG CTG TA   
     
ISAba-1 tnpA eHRF CAC GAA TGC AGA AGT TG 95
oC(1 ) 50oC (45 ) 72oC (45 ) 550 
 eHRR CGA CGA ATA CTA TGA CAC   
     
* - initial denaturation was 95oC for 5 minutes and final elongation was 72oC for 5 minutes for all assays. Conditions were cycled 35 
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2.7 Sequencing and sequence analysis  
Purified PCR products and recombinant plasmids were sequenced using the ABI Prism® 
BigDye™ Terminator Cycle Sequencing kit (Applied Biosystems, USA) according to the 
manufacturer’s instructions. Additional primers were designed and used for sequencing reactions 
to complete the entire sequence. The dideoxy sequence reaction protocol was followed. The 
dideoxy method utilises a DNA polymerase to catalyse the synthesis of DNA in the presence of 
modified deoxy and dideoxynucleotides (Garrett & Grisham, 2005). The polymerase is 
genetically engineered and lacks all traces of exonuclease activity that might otherwise degrade 
the DNA. Chain elongation occurs from the 3′ end of a DNA primer that is annealed to the target 
template DNA until a dideoxynucleotide is incorporated. Elongation is terminated as the 
dideoxynucleotide is modified and lacks a 3′ hydroxyl group. The products are thus a population 
of oligonucleotide fragments whose lengths are determined by the distance between the 
5′ termini of the primer used to initiate DNA synthesis and the sites of the dideoxynucleotide 
termination. Four reactions are run in parallel, each with a dNTP labeled with one of four different 
fluorescent dyes to provide a tracer for the products of the polymerization process. The 
sequencing products are visualized by autoradiography following their separation on a 
polyacrylamide gel based on their size. Smallest fragments migrate the fastest upon 
electrophoresis and fragments differing by a single nucleotide are readily resolved. As the 
differently sized fragments pass down the gel, a laser beam excites the dye and the emitted 
energy is detected by a fluorometer. The emitted light identifies the final base in the fragment. 
This way, a whole sequence is determined and will be displayed as a graph using computer 
based programs. 
Automated sequencing was performed at the Core Sequencing Facility at the University of 
Stellenbosch, Cape Town. Sequences were edited in Chromas (Version 2.31, Techelysium Pty 
Ltd) and analysed using DNAMAN software (Version 4.0, Lynnon Biosoft). A standard 
nucleotide-nucleotide BLAST analysis (blastn; www.ncbi.nlm.nih.gov/BLAST) of the GenBank 
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2.8 Southern hybridisation 
2.8.1 Preparation of labelled probe 
Gel extracted (2.3.3) PCR products (2.6) were used as probes in Southern hybridisation 
experiments. The probe was diluted to 10 ng/μl and denatured by boiling for five minutes. Rapid 
cooling on ice for five minutes kept the denatured probe from reannealing before 10 μl of the 
labeling reagent (horseradish peroxidase; Amersham, UK) was added. The peroxidase is 
complexed with a positively charged polymer that forms ionic interactions with the negatively 
charged single-stranded DNA probe. Addition of an equal volume of gluteraldehyde causes 
covalent bond formation between the probe and peroxidase as the mixture is incubated at 37oC 
for 10 minutes. 
 
2.8.2 Hybridisation, signal generation and detection 
Genomic DNA (5 μg) was digested (2.3.1) for 6 hours and electrophoresed on a 0.8 % agarose 
gel (2.3.2) at 30 volts overnight. The gel was washed for 15 minutes in 0.25 M depurinating 
buffer (Appendix A), twice for 20 minutes in denaturing buffer (1.5 M NaCl and 0.5 M NaOH; 
Appendix A), and twice for 20 minutes in neutralising buffer (1.5 M NaCl, 0.5 M Tris-HCl, pH 7.5; 
Appendix A). The gel was rinsed with distilled water between each of the washes. The single 
stranded genomic DNA was immobilized overnight onto a Hybond-N+ membrane (Amersham, 
UK) by capillary transfer. Immobilizing allows for downstream manipulation of the DNA to detect 
required sequences using a specific probe. 
The transferred DNA was fixed onto the Hybond-N+ membrane by cross-linking with a UV fixer 
(Hoefer Scientific Instruments, USA) for 1200 counts at wavelength of 245 nm. Cross-linking is 
achieved by the formation of bonds between the positively charged amino groups on the 
membrane and the thymine residues in DNA (Khandjian, 1986). The membrane was incubated at 
42oC in a hybridization oven (Techne Hybridisation HB 1D, England) with gentle shaking in 
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The probe was added to the prehybridization buffer and left to hybridize over night at 42oC. Two 
20 minute washes with primary wash buffer (Appendix A) at 42oC were sufficient to remove 
unbound probe from the membrane. Following two five-minute washes with secondary wash 
buffer (Appendix A), the membrane was incubated for a minute in a mixture of equal volumes of 
detection reagent 1 and 2 (Amersham, UK). Detection reagent 1 decays to hydrogen peroxide. 
The hydrogen peroxide is reduced to water and oxygen by the peroxidase bound to the probe 
(2.8.1). The oxygen produced oxidizes luminol in detection reagent 2 to produce light. 
The presence of an enhancer in the detection reagents prolongs and increases the light output, 
allowing it to be detected on a blue-light sensitive film. After excess detection reagent was 
drained off, the blot was wrapped in cling film, placed in a film cassette and exposed to an X-ray 
film (AGFA, CP-BU, 100NIF) for a minute, or longer if necessary. The film was then placed in 
developer (G128, AGFA, Belgium) for 3 minutes, briefly rinsed in tap water, and placed in Rapid 
fixer (G333C, AGFA, Belgium) for 3 minutes. Following a brief rinse in tap water, the film was 
hung to dry and scanned using a Canon scanner, CanoScan 5600F (Japan). 
 
2.9 RNA extraction and purification 
RNA was extracted from bacterial cultures at time points corresponding to logarithmic and 
stationary phases. Using the hot acid phenol procedure (Aiba et al, 1981), harvested cells were 
resuspended in 0.02 M sodium acetate, 0.5 % SDS and 1 mM EDTA (acetate/SDS buffer). 
Samples were incubated with gentle shaking at 60oC in the presence of redistilled phenol. The 
aqueous phase was re-extracted with phenol and the RNA chilled at -70oC in 70 % ethanol. 
Following resuspension of the precipitate in acetate/SDS buffer, the RNA was ethanol 
precipitated two more times and finally resuspended in 50 μl RNase-free distilled water. The RNA 
was quantified using a Nanodrop spectrophotometer, ND-1000 UV/Vis (USA) and the quality 
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To remove contaminating DNA from RNA samples prior to reverse-transcriptase PCR (2.10), the 
RNA was treated with RQ1 DNase (Promega, USA), an endonuclease that cleaves double- and 
single-stranded DNA molecules. The DNase was added at a concentration of 1 unit per 
microgram of RNA together with the appropriate buffer. The reaction was made up to 10 μl with 
RNase-free distilled water and incubated for 30 minutes at 37oC. To inactivate the DNase which 
may interfere with downstream reactions, a microlitre of RQ1 DNase stop solution was added 
and incubated at 65oC for 10 minutes. 
 
2.10 Reverse transcriptase PCR 
Reverse transcriptase PCR is a technique used to determine gene expression. An RNA-
dependant DNA polymerase is used to synthesise cDNA from RNA transcripts in the presence of 
a reverse primer. The cDNA obtained is then used as template in a standard PCR (2.6). 
A 15 μl reaction with DNase treated RNA (2 μl; 2.9) and reverse primer (0.5 μg) complementary 
to the gene of interest was incubated for five minutes at 70oC to denature the RNA secondary 
structure. Following rapid cooling on ice, the reverse transcriptase moloney murine leukaemia 
virus (M-MLV, 200 units; Promega, USA), 5 μl 5 X M-MLV reaction buffer, 10 μl nuclease-free 
dNTPs, and 25 units of Recombinant RNasin® Ribonuclease Inhibitor (Roche, Germany) were 
added. The reaction was made up to 25 μl with RNase-free distilled water and incubated at 42oC 
for an hour to synthesize cDNA. 
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3.1 Investigation of the presence of an interrupted ATPase gene in A. baumannii strains 
MOS1 and MOS2    
An A. baumannii isolate, MOS1, was obtained from a patient admitted to GSH in 2005.  
Susceptibility tests indicated that MOS1 was resistant to the aminoglycosides gentamicin and 
amikacin, and susceptible to meropenem and imipinem (Table 2.1). PCR assays indicated that 
MOS1 contains a copy of aacC2a downstream of an ISAba-1-interupted copy of IS1133 (Figure 
3.1; Jacobson, 2007). 
 
 
Figure 3.1: Genetic arrangement of an aminoglycoside resistance gene, aacC2a (yellow), downstream of an IS1133 
portion (red). IS1133 is interrupted by a full copy of ISAba-1 (purple) in strain MOS1. This genetic arrangement has 
been conserved for almost 26 years in A. baumannii clinical isolates from Cape Town. The arrows indicate direction 
of transcription (Adapted from Jacobson, 2007). 
 
MOS2, isolated two weeks later from the same patient following treatment with meropenem, was 
resistant to gentamicin, amikacin, imipinem and meropenem. MOS2 did not carry a copy of 
aacC2a (Jacobson, 2007). Resistance to gentamicin and amikacin in this strain may be due to 
the expression of other aminoglycoside resistance genes (Table 1.1; Bergogne-Berezin & 
Towner, 1996), overexpression of the AdeABC multidrug efflux pump (1.3.2; Magnet et al., 
2001), methylation of the 16S rRNA (1.3.4; Lee et al., 2006), or a combination of these 
mechanisms.             
Notably, MOS2 had a copy of blaOXA-23 (Segal et al., 2007), which would account for the 
carbapenem resistance in this isolate. MOS1 did not carry a copy of blaOXA-23 (Segal et al., 2007). 
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blaOXA-23  gene replaced the conserved genetic arrangement, possibly present on a large mobile 
genetic element in MOS1, following horizontal gene transfer. Integrons are associated with gene 
cassettes that have a 59 base on their 3'- end (Figure 1.5; Recchia & Hall, 1995). Sequence 
analysis of the conserved genetic arrangement (Figure 3.1) did not reveal the presence of a 59 
base element, indicating that this arrangement does not contain features of an integron. 
Therefore, should MOS1 harbour a large IS1133L/ISAba-1/IS1133R-aacC2a-associated mobile 
genetic element, it may be part of a transposon or a PAI located on either a plasmid or within the 
chromosomal DNA of this strain. 
Transposons, PAIs, and other large genomic regions are located within the ATPase gene of 
A. baumannii (Fournier et al., 2006; Corvec et al., 2007; Iacono et al., 2008; Shaikh et al., 2009). 
To determine whether the ATPase gene was interrupted in MOS1 and MOS2, a PCR assay (2.6) 
with primers 42-156F and 46-358R (Table 2.3; Figure 3.2; Fournier et al., 2006) was carried out. 
The primers 42-156F and 46-358R amplify a 253 bp region within the ATPase structural gene 


































Figure 3.2: Nucleotide sequence of a partial ATPase gene. The primers used in the study by Fournier and colleagues (2006) to detect for the presence of an 
interrupted ATPase gene are highlighted in green. The primers used by Shaikh and colleagues are highlighted in yellow. The direction of the primers is indicated by 
arrows. The 5' and 3' – ends of the ATPase gene are indicated on the left. The region between the 5' and 3' where large genomic regions can insert is indicated by 
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A. baumannii strain A21 is susceptible to most of the clinically available antibiotics except 
amikacin. This isolate was therefore included as a positive control in the absence of a strain with 
a known intact ATPase gene. A no DNA control was also included to detect the presence of 
contamination in the PCR reagents. Following PCR amplification, the PCR amplicons were 
analysed by agarose gel electrophoresis (2.3.2). 
No product was obtained from the no DNA control, indicating no contamination of the reagents 
used. A product of the expected size (253 bp) was not obtained from the susceptible strain A21. 
Following a number of optimisations including increasing the annealing time to four minutes to 
allow for amplification of larger products, no product was obtained from A21. A 20 kb AbaG1 
genomic island interrupted an ATPase gene in the A. baumannii susceptible isolate SDF 
(Fournier et al., 2006). Another isolate, A. baumannii ATCC 17978 (Bauman et al., 1968), had a 
13 kb genomic island inserted within an ATPase gene (Iacono et al., 2008). The presence of 
such a large insertion in the ATPase gene of A21 would prevent amplification of the 253 bp 
region in this PCR assay and could account for the lack of product observed.  
Following amplification, no 253 bp PCR product was obtained from MOS1, suggesting the 
presence of a disrupted ATPase gene in this isolate. The IS1133L–aacC2a genomic region in 
MOS1 is 3 397 bp (Figure 3.1). Should this arrangement lie on a large mobile element inserted 
within the ATPase gene in MOS1, the mobile element would be greater than 3 397 bp. 
Sequences downstream of the IS1133L–aacC2a conserved genetic arrangement have been 
characterised in a pre ious study (Figure 3.3; Segal et al., 2003). Primers on either side of this 
region, IS26F2 and IS1133F5 (Table2.3; Figure 3.3), were used in combination with the ATPase-
specific primers, 42-156F and 46-358R (Table 2.3; Fournier et al., 2006), to identify further 
sequences that may be associated with putative transposons or PAIs in MOS1. IS26F2 and 
IS1133F5 are complementary to sequences within the IS26 and IS1133L portion, respectively. 
A21 and MOS2 were included as negative controls as they do not harbour the IS1133L–aacC2a 
conserved genetic arrangement (Jacobson, 2007). Following amplification, the PCR products 

















Figure 3.3: Schematic representation of sequences associated with aacC2a (yellow; Segal et al., 2003): hpg, hypothetical protein; insertion sequence element, IS26; 
intI1, a portion of an integrase gene; IRi, left inverted repeat flanking integrons; tnpR and tnpM are Tn21-related sequences. The bracket shows the region that has 
been conserved for over 25 years in A. baumannii isolates obtained from patients at Groote Schuur and Red Cross children’s hospitals. The closed arrows indicate 
direction of transcription. The open arrows indicate primers used to identify sequences on either side of the insert (Jacobson, 2007). A putative interrupted ATPase 
gene is indicated in brown.  The dots represent unknown sequence that may form part of a putative genomic island. The expected product sizes used in combination 
with ATPase specific primers are indicated. 
IS1133∆ tnpR tnpM intI1 IS26 IRi hpg aacC2a ISAba-1 IS1133∆ 
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As expected, no product was obtained from the no DNA control or from A21 or MOS2 as these 
isolates do not contain a copy of IS1133. The absence of a PCR product from MOS1 suggests 
the location of the IS1133L/ISAba-1/IS1133R-aacC2a conserved region on a large genomic 
region in MOS1. However, in the absence of control strains with an intact ATPase gene and one 
with an interrupted ATPase gene, it is difficult to interpret the results conclusively.  
A. baumannii has an impressive ability to acquire resistance genes from other pathogens through 
horizontal gene transfer (Mah et al., 2001; Landman et al., 2002). The acquired resistance genes 
are often inserted in large genomic regions like transposons and PAIs. PAIs range from 10 – 200 
kb (Schmidt & Hensel, 2004) in pathogenic bacteria, with the largest PAI identified in 
A. baumannii being 86 kb (Fournier et al., 2006). PCR amplification using Taq polymerase 
proceeds at 1 minute/kb of genomic DNA (Promega, USA). Identification of large genomic 
regions in A. baumannii therefore requires elongation times greater than that which can be 
achieved using Taq polymerase.  
In a study by Fournier and colleagues (2006), 5 of 22 A. baumannii isolates gave no PCR 
products with the ATPase-specific primers, 42-156F and 46-358R (Table 2.3).  The presence of 
a large mobile genetic element inserted within an ATPase gene was suggested (Fournier et al., 
2006) and confirmed using whole genome sequencing. Thus, the identification and 
characterisation of such large regions of the genome would more readily be achieved through 
whole genome sequencing. In the study by Shaikh and colleagues (2009), a total of 10 
A. baumannii isolates yielded no product in PCR assays using primers that flanked the ATPase 
insertional region (Figure 3.2). However, further investigation of the 10 isolates indicated that 
eight isolates carried ATPase genes interrupted by large genomic islands. Thus, even though the 
PCR fails to yield any amplicons, there is still a possibility that the ATPase gene will be 
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3.2. Characterisation of sequences associated with aacC2a in A. baumannii MOS1 
The sequences downstream of the IS1133L/ISAba-1/IS1133R-aacC2a conserved region have 
been characterised (Figure 3.3; Segal et al., 2003). In the absence of whole genome sequencing, 
a standard cloning procedure (Sambrook et al., 1989) was used to detect sequences upstream of 
the IS1133L/ISAba-1/IS1133R-aacC2a genetic arrangement. 
To obtain sequences upstream of IS1133, an EcoRI/BamHI genomic DNA library of MOS1 was 
constructed (2.3.1; 2.4; 2.5) since the IS1133L/ISAba-1/IS1133R-aacC2a genetic arrangement 
does not have EcoRI or BamHI restriction sites. Recombinant isolates were selected on agar 
containing gentamicin since the aminoglycoside resistance gene, aacC2a, confers resistance to 
gentamicin and tobramycin (Seward et al., 1998; Nemec et al., 2004). Recombinant E. coli 
JM109 growing in the presence of gentamicin selection would therefore contain a copy of 
aacC2a gene, along with the associated genetic arrangement (Figure 3.1), including sequences 
upstream of IS1133 tnpA. 
To eliminate the digestion buffer and restriction enzymes that may interfere with downstream 
manipulation of the DNA, the genomic DNA was purified by ethanol precipitation (2.3.4) and the 
plasmid by the agarose gel extraction pr tocol (2.3.3). The quality of the DNA was analysed by 












- 64 - 
 
 
Figure 3.4: Agarose gel electrophoresis following digestion of genomic DNA and pUC19 used to construct a MOS1 
EcoRI/BamHI genomic library. a) MOS1 genomic DNA used for library construction Lane 1: Hyperladder 1 (Bioline; 
Appendix C); Lane 2: undigested MOS1 genomic DNA; Lane 3: EcoRI/BamHI digested MOS1 genomic DNA before 
purification; Lane 4: EcoRI/BamHI digested MOS1 genomic DNA following purification by ethanol precipitation 
(2.3.4). b) pUC19 used for library construction Lane 1: Hyperladder 1 (Bioline; Appendix C); Lane 2: undigested 
pUC19; Lane 3: gel purified EcoRI/BamHI digested pUC19 
 
Undigested MOS1 genomic DNA (Figure 3.4a; Lane 2) was included to check the efficiency of 
digestion. A product of the expected size, 2 686 bp, was obtained for linear pUC19 (Figure; 3.4b; 
Lane 3). Undigested pUC19 (Figure 3.4b; Lane 2) was included to check the efficiency of 
digestion. The undigested pUC19 (Figure 3.4b; Lane 2) is circular and supercoiled and therefore 
migrates faster than the linear pUC19 on an agarose gel. 
Following ligation (2.4), competent cells were transformed in the absence of any plasmid to 
ensure that they were not contaminated with pUC19. The transformation efficiency of the 
competent cells, calculated as (number of colonies/ concentration of transformed pUC19) x 
(103ng/µg) x dilution factor, was determined by transforming the cells with undigested pUC19. 
The efficiency of the ligase enzyme was determined by transforming competent cells with 
religated pUC19 previously digested with EcoRI. The transformation efficiency of the ligase 
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control was then compared to that obtained using undigested pUC19. To ensure the digestion of 
pUC19, apart from analysis on an agarose gel (Figure 3.4b; Lane 3), competent cells were 
transformed with linear pUC19.  Competent cells should not take up linear DNA. Following 
transformation of the ligation mix into E. coli JM109 competent cells (2.5), recombinants were 
selected for on agar containing gentamicin, X-gal and IPTG (2.5; Table 3.1). 
 
Table 3.1. E. coli JM109 transformants obtained using pUC19 and MOS1 
Sample transformed Colonies 
No DNA control 0 
  
Undigested pUC19 1 083 
  
Religated pUC19 97 
  
Linear pUC19 0 
  






No recombinants were obtained from the no DNA control following transformation of competent 
cells in the absence of pUC19 (Table 3.1) indicating that the competent cells were not 
contaminated. The competent cells used in this study had a transformation efficiency of 1.083 x 
109 cfu/μg (Table 3.1) and therefore appropriate for use in this cloning procedure. A 
transformation efficiency of 9.7 x 107 cfu/μg was obtained from the ligase efficiency control 
(Table 3.1), indicating the efficiency of the ligase enzyme to religate digested DNA. There were 
no colonies obtained following transformation of the E. coli JM109 competent cells with linear 
pUC19 (Table 3.1), indicating complete digestion of the cloning vector. 
A total of 95 recombinants were obtained from E. coli JM109 cells transformed with pUC19 
ligated to EcoRI/BamHI digested MOS1 genomic DNA following selection on gentamicin (Table 
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resistance genes apart from aacC2a (Bergogne-Berezin & Towner, 1996). To ensure that 
gentamicin resistance in these recombinants was due to the expression of aacC2a and to screen 
for sequences upstream of the IS1133L/ISAba-1/IS1133R-aacC2a genetic arrangement, the 
library was screened for aacC2a. The aacC2a-specific primers aacC2aF and aacC2aR (Table 




Figure 3.5: Schematic representation of aacC2aF and aacC2aR primers (arrows) in relation to the conserved 
genetic region in A. baumannii strain MOS1. A 786 bp product is obtained in a PCR assay using the indicated 
primers. IS1133 (red) is interrupted by a full copy of ISAba-1 (purple). (Adapted from Jacobson, 2007). 
  
A no DNA control was included to detect contamination. E. coli JM109, E. coli JM109 (pUC19), 
and pUC19 were included to ensure that aacC2aF and aacC2aR primers were not 
complementary to sequences within the E. coli JM109 genome or pUC19. MOS1 genomic DNA 
obtained from the boiling method and from the phenol/chloroform method (2.2.1) was included as 
positive controls. Following PCR amplification, the amplicons were analysed by agarose gel 
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Figure 3.6: PCR amplicons of the aacC2a gene from MOS1 EcoRI/BamHI recombinant clones. Lane 1: 
Hyperladder IV (Bioline; Appendix C); Genomic DNA extracted from transformants in pools 1-10 (Lanes 2-11) were 
included; Lane 12: E. coli JM109; Lane 13: E. coli JM109 (pUC19); Lane 14: pUC19; Lane 15: MOS1 (genomic 
DNA obtained from the boiling method); Lane 16: MOS1 (genomic DNA obtained from phenol/chloroform 
extraction); Lane 17: no DNA control. The arrow indicates the size of the product corresponding to the aacC2a gene 
(786 bp) and relevant marker sizes are indicated. 
 
No product was obtained from the no DNA control (Figure 3.6; Lane 17), indicating that the PCR 
reagents used in this assay were not contaminated. Non-specific amplification was observed with 
the negative controls E. coli JM109 and E. coli JM109 (pUC19) indicating regions complementary 
to aacC2aF and aacC2aR in E. coli JM109 and pUC19. Optimisations of the assay did not inhibit 
this non-specific amplification. A product of the expected size (786 bp) corresponding to the 
aacC2a structural gene, was obtained from the two MOS1 positive controls (Figure 3.6; Lanes 15 
and 16). All 10 pools gave a product of the expected size following amplification with aacC2aF 
and aacC2aR primers, (Figure 3.6; Lanes 2-11), suggesting the presence of an EcoRI/BamHI 
insert harbouring the IS1133L/ISAba-1/IS1133R-aacC2a genetic arrangement in all the colonies.  
To determine which of the recombinant colonies from all pools resulted in the PCR products 
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carried out on individual colonies from each of the 10 pools. A product of 786 bp, corresponding 
to aacC2a, was obtained from all 95 colonies (data not shown). Thirty-five recombinant clones 
were randomly selected for small-scale plasmid extraction (2.2.2). The plasmid pUC19 was 
extracted from E. coli JM109 (pUC19) as a positive control.  Following plasmid extraction, the 
plasmids were electrophoresed on a 1 % agarose gel (Figure 3.7).                                                 
 
 
Figure 3.7: Agarose gel electrophoresis of DNA extracted from selection of recombinant clones of a MOS1 
EcoRI/BamHI library.  Lane 1: Hyperladder I (Bioline); Lane 2 – 6: clones 1-5; Lane 7: pUC19.  
 
The plasmid pUC19 was extracted from E. coli JM109 (Figure 3.7; Lane 7). No plasmids were 
obtained from any of the thirty-five transformants (data not shown). It may be that the 
recombinant plasmids were unstable and integrated into the E.coli JM109 genome. Should this 
be the case, a recombination site may lie directly or many nucleotides upstream of the 
IS1133L/ISAba-1/IS1133R-aacC2a genetic arrangement in MOS1.  
Although all of the recombinant clones were positive for the aacC2a PCR (Figure 3.6), no 
recombinant plasmids were obtained from the MOS1 EcoRI/BamHI recombinant clones (Figure 
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E. coli JM109 genome. A PCR assay (2.6) using the primers IS1133F5 and M13R (Table 2.3; 
Figure 3.8) was carried out on five recombinants. IS1133F5 is complementary to sequences in 
the left portion of IS1133 (Figure 3.8). M13R is a pUC19-specific primer that lies just outside of 



















Figure 3.8: Schematic representation of a putative EcoRI/BamHI recombinant plasmid from A. baumannii strain 
MOS1. The restriction sites are indicated. IS1133 interupted by a full copy of ISAba-1 is indicated in red. Unknown 
sequences upstream of ∆ IS1133 are indicated in blue. M13 primers are indicated in green and the IS1133F5 primer 
as a red arrow. aacC2a, aminoglycoside resistance gene; hpg, hypothetical protein; insertion sequence element, 
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A no DNA control was included to detect contamination. The plasmid pRK002 (Appendix B; 
Jacobson, 2007) contains the conserved genetic arrangement (Figure 3.1), and was included as 
a positive control. Following amplification, the PCR products were analysed by agarose gel 
electrophoresis (2.3.2; Figure 3.9). 
 
 
Figure 3.9: Agarose gel electrophoresis following PCR amplification with the primers IS1133F5 and M13R on MOS1 
EcoRI/BamHI recombinant clones. Lane 1: pRK002 (Appendix B); Genomic DNA extracted from five randomly 
selected transformants (Lanes 2-6) was included; Lane 7: no DNA control. Lane 8: Hyperladder I (Bioline; Appendix 
C). Relevant marker sizes are indicated and an expected product size (1 014) indicated by an arrow. 
 
No product was obtained from the no DNA control (Figure 3.9; Lane 7), indicating that the PCR 
reagents used in this assay were not contaminated. A product of the expected size (1 014 bp) 
corresponding to the region between IS1133F5 and M13R (Table 2.3), was obtained from the 
positive control, pRK002 (Appendix B; Figure 3.9; Lane 1). There was no product of the expected 
size (> 1 014 bp) obtained from any of the clones used to test for recombination (Figure 3.9; 
Lanes 2-6), suggesting that the recombinant plasmid may have been very large and unstable 
and that it integrated into the E. coli JM109 genome, or that there may be a recombination site 
upstream of the left portion of IS1133. 
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As sequences upstream of the IS1133L-aacC2a-associated genetic arrangement could not be 
obtained from the MOS1 EcoRI/BamHI library, another genomic library, using different restriction 
enzymes, was constructed. 
MOS1 genomic DNA and pUC19 were therefore digested with EcoRI and HindIII (2.3.1 Figure 
3.10a). Importantly, there is a HindIII site in the right hand portion of IS1133. Recombinants 
obtained would therefore contain more sequence upstream of the right hand portion of IS1133. 
EcoRI digested pUC19 was included to investigate the efficiency of the ligase enzyme (Figure 
3.10b; Table 3.2). Following purification (2.3.3; 2.3.4) of EcoRI and BamHI MOS1 genomic DNA 
and pUC19, the quality of the DNA was analysed by agarose gel electrophoresis (2.3.2; Figure 
3.10).  
                   
Figure 3.10: Agarose gel electrophoresis following MOS1 genomic DNA and pUC19 digestion. a) Lane 1: 
Hyperladder 1 (Bioline; Appendix C); Lane 2: EcoRI/HindIII digested pUC19; Lane 3: EcoRI/HindIII digested pUC19 
following agarose gel purification (2.3.3); Lane 4: BLANK; Lane 5: EcoRI/HindIII digested MOS1 genomic DNA; 
Lane 6: EcoRI/HindIII digested MOS1 genomic DNA following purification by ethanol precipitation (2.3.4). b) EcoRI 
digested pUC19 used as a ligation control Lane 1: Hyperladder 1 (Bioline; Appendix C); Lane 2: undigested pUC19 
Lane 3: EcoRI digested pUC19; Lane 4: EcoRI digested pUC19 following agarose gel purification (2.3.3). Marker 
sizes are indicated and the arrow indicates the 2 686 bp product of linear pUC19. 
 
A product of the expected size, 2 686 bp, was obtained for linear pUC19 (Figure; 3.10a; Lane 3 
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efficiency of digestion. The undigested pUC19 (Figure 3.10b; Lane 2) is circular and supercoiled 
and therefore migrates faster than the linear pUC19 on an agarose gel. 
Following ligation (2.4), competent cells were transformed in the absence of any plasmid to 
ensure that they were not contaminated with pUC19. The efficiency of the ligase enzyme was 
determined by transforming competent cells with religated pUC19 previously digested with EcoRI 
(Figure 3.10b). To ensure the digestion of pUC19, apart from analysis on an agarose gel (Figure 
3.10a; Lanes 3 and 4), competent cells were transformed with linear pUC19.  Following 
transformation of the ligation mix into E. coli JM109 competent cells (2.5), recombinants were 
selected for on agar containing ampicillin, X-gal and IPTG (2.5; Table 3.2). 
 
Table 3.2.  E. coli JM109 transformants obtained using pUC19 and MOS1 
Sample transformed Colonies 
No DNA control 0 
  
Undigested pUC19 906 
  
Religated pUC19 148 
  
Linear pUC19 0 
  
pUC19 (EcoRI/HindIII) + MOS1 (EcoRI/HindIII) 423 
  
 
No recombinants were obtained from the no DNA control following transformation of competent 
cells in the absence of pUC19 (Table 3.2) indicating that the competent cells were not 
contaminated. The competent cells used in this study had a transformation efficiency of 
9.06 x 108 cfu/μg (Table 3.2) and therefore appropriate for use in this cloning procedure. A 
transformation efficiency of 1.48 x 108 cfu/μg was obtained from the ligase efficiency control 
(Table 3.2), indicating the efficiency of the ligase enzyme to religate digested DNA. There were 
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pUC19 (Table 3.2), indicating complete digestion of the cloning vector. A total of 423 colonies 
were obtained from the MOS1 EcoRI/HindIII genomic DNA library (Table 3.2). 
To screen the genomic library, the primers IS1133F2 and IS1133F5 (Jacobson, 2007; Table 2.3; 
Figure 3.11) were used in a PCR assay (2.6) on DNA obtained from pools of 10 recombinants 
(2.2). The primers IS1133F2 and IS1133F5 are complementary to sequences in the IS1133 
portion that habours the left inverted repeat.  
 
 
Figure 3.11: Schematic representation of the conserved genetic arrangement in A. baumannii strain MOS1. IS1133 
(red) is interrupted by a full copy of ISAba-1 (purple); this genetic arrangement lies upstream of an aminoglycoside 
resistance gene, aacC2a (yellow). A HindIII site (open arrow) lies downstream of the IS1133F5 primer. IS1133F2 
and IS1133F5 primers are indicated by arrows. A 949 bp product is obtained in a PCR assay using the indicated 
primers. (Adapted from Jacobson, 2007).  
 
PCR products were analysed by agarose gel electrophoresis (2.3.2; Figure 3.12). Recombinants 
with a positive PCR product would harbour the left inverted repeat of IS1133 and sequences 
flanking this region. A no DNA control was included to detect contamination. E. coli JM109 
(pUC19), was included to ensure that IS1133F2 and IS1133F5 primers were not complementary 
to sequences within the E.coli JM109 genome or pUC19.  
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Figure 3.12: Agarose gel electrophoresis following PCR amplification of a portion of IS1133 in MOS1 EcoRI/HindIII 
recombinant clones. Lane 15: Hyperladder IV (Bioline; Appendix C). Genomic DNA extracted from transformants in 
pools 1-14 (Lanes 1-14) and pools 15-23 (Lanes 15-24) were included. Lane 25: E. coli JM109 (pUC19); Lane 26: 
no DNA control; Lane 27: MOS1. The open arrow corresponds to pool 19 in which a positive result was obtained. 
The closed arrow indicates the size of the product corresponding to the left hand portion of IS1133 (949 bp) and 
relevant marker sizes are indicated.  
 
No product was obtained from the no DNA control (Figure 3.12; Lane 26), indicating that the 
PCR reagents used in this assay were not contaminated. No product was obtained from the 
E. coli JM109 (pUC19) negative control (Figure 3.12; Lane 25), indicating that there are no 
regions complementary to the left hand portion of IS1133 in E. coli JM109 or pUC19. A product 
of the expected size (949 bp) corresponding to the left hand portion of IS1133, was obtained 
from the positive control, MOS1 (Figure 3.12; Lane 27). Of the 423 transformants screened, only 
pool 19 (clones 181-190) yielded a 949 bp product (Figure 3.12; Lane 20).  
To determine which of the ten recombinant colonies included in pool 19 resulted in the PCR 
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3.10) were carried out on the individual colonies in pool 19 (Figure 3.13). MOS2 was included as 
a negative control as it does not harbor the insertion sequence IS1133 (Jacobson, 2007). 
 
 
Figure 3.13: Agarose gel electrophoresis following PCR amplification of a portion of IS1133 from recombinant 
clones in pool 19. Lane 1: Hyperladder IV (Bioline; Appendix C). Genomic DNA extracted from transformants 181-
190 (Lanes 2-11) were included. Lane 12: E. coli JM109 (pUC19); Lane 13: no DNA control; Lane 14: MOS2; Lane 
15: MOS1. The open arrow corresponds to clone 183 in which a positive result was obtained. The closed arrow 
indicates the size of the product corresponding to the left hand portion of IS1133 (949 bp) and relevant marker sizes 
are indicated.  
 
No product was obtained from E. coli JM109 (pUC19) (Figure 3.13; Lane 12), no DNA control 
(Figure 3.13; Lane 13) or MOS2 (Figure 3.13; Lane 14). Thus, the PCR reagents used in this 
assay were not contaminated and there are no sequences complementary to the primers 
IS1133F2 and IS1133F5 in MOS2 or E. coli JM109 (pUC19). A product of the expected size (949 
bp) was obtained from the positive control, MOS1 (Figure 3.13; Lane 15). Only one colony (clone 
183) gave a 949 bp product corresponding to the presence of the left hand portion of IS1133. 
The plasmid from clone 183, designated pTJ001 (Appendix B), was extracted (2.2.2) and 
digested with EcoRI and HindIII (2.3.1) to determine the size of the insert (Figure 3.14). The 
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Figure 3.14: Agarose gel electrophoresis of pTJ001 digested with EcoRI and HindIII. Lane 1: Hyperladder 1 
(Bioline; Appendix C); Lane 2: EcoRI/HindIII digested pUC19; Lane 3: EcoRI/HindIII digested pTJ001. The arrows 
indicate fragments of pTJ001. Marker sizes are indicated. 
 
Inserts of 1 586 bp and 239 bp were obtained (Figure 3.14) following digestion of pTJ001 with 
EcoRI and HindIII. Since the IS1133F2 -IS1133F5 PCR gives a 949 bp product it was likely that 
the 1 586 bp, not the 239 bp, insert contained a portion of IS1133. The 1 586 bp insert was 
therefore extracted (Figure 3.15) and purified (2.3.3).  
 
Figure 3.15: Agarose gel extracted 1 586 bp fragment from an EcoRI/HindIII digested pTJ001 obtained from the 
recombinant clone 183.  Lane1: Hyperladder 1 (Bioline; Appendix C); Lane 2: undigested pTJ001; Lane 3: EcoRI/ 
HindIII – digested pTJ001 with the 1 586 bp insert excised. The arrows indicate linear pUC19 (2 686 bp) and the two 
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Undigested pTJ001 (Figure 3.15; Lane 2) was included to check the efficiency of digestion. The 
undigested pTJ001 is in an open circular conformation and therefore migrates slower than the 
linear pUC19 on an agarose gel.  
An IS1133F2 -IS1133F5 PCR (Table 2.3; Figure 3.10) was performed on the gel extracted insert 
to confirm the presence of the left hand portion of IS1133 on this fragment. The plasmid pUC19 
was included as a negative control and pTJ001 as a positive control (Figure 3.16).  
 
 
Figure 3.16: Agarose gel electrophoresis of IS1133F2 -IS1133F5 PCR on a 1 586 bp fragment obtained from an 
EcoRI/HindIII digested pTJ001. Lane 1: Hyperladder IV (Bioline; Appendix C); Lane 2: no DNA control; Lane 3: 
pUC19; Lane 4: pTJ001; Lane 5: gel extracted 1 586 bp fragment. The arrow indicates the expected product size of 
949 bp. The marker sizes are indicated 
 
No product was obtained from the no DNA control nor from pUC19 (Figure 3.16; Lane 2 and 3). 
A product of the expected size (949 bp) was obtained from the positive control, pTJ001 (Figure 
3.16; Lane 4). A 949 bp product was obtained from the gel purified 1 586 bp EcoRI/HindIII 
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The recombinant plasmid pTJ001 (Figure 3.17) was sequenced on both strands (2.7) using the 
primers M13F (5'-GTA AAA CGA CGG CCA GT-3'; Figure 3.17), M13R (Table 2.3; Figure 3.17), 
IS1133F2 and IS1133F5 (Table 2.3). M13F and M13R are pUC19-specific primers that lie just 
outside the multiple cloning site (MCS; Appendix B). Following analysis of the sequencing data 
obtained from pTJ001, it was determined that pTJ001 contained a concatemer of three inserts (1 













Figure 3.17: Schematic representation of pTJ001. A 1 586 bp HindIII fragment obtained from a MOS1 EcoRI/HindIII 
genomic DNA library is indicated in red and green. A partial ISKpn12 gene (green) lies 108 bp downstream of an 
IS1133 portion (red). Two other inserts on pTJ001 are represented as a black block. The pUC19-specific primers 
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The 125 bp insert was not visible on the agarose gel (Figure 3.14, Lane 3; Figure 3.15, Lane 3) 
as it may have migrated off the end of the gel since it is a small fragment that would migrate 
faster on a 1 % agarose gel. The 239 bp and 125 bp inserts were homologous to A. baumannii 
genomic DNA encoding a hypothetical protein and a conserved region in a ferredoxin-dependent 
glutamase synthase protein, respectively, and are not associated with the aacC2a-associated 
genetic arrangement. 
Analysis of the 1 586 bp insert of pTJ001 indicated 558 bp upstream of IS1133 (Figure 3.18). 
This region contained an ORF of 351 bp that showed 100 % homology to the recently published 
sequence of ISKpn12 tnpA (Márquez et al., 2008). To complete the sequence on both strands, 
primers complementary to the tnpA, ISKpn12F and ISKpn12R (Table 2.3; Figure 3.18), were 
designed and used for sequencing pTJ001. 
ISKpn12 is an 842 bp insertion sequence (Márquez et al., 2008) that belongs to group IS427 of 
the IS5 family of IS elements (Table 1.2; Mahillon & Chandler, 1998). ISKpn12 is flanked by a 10 
bp inverted repeat and contains an ORF of 351 bp that encodes its tnpA (Figure 3.18). The 
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3.3 Characterisation of ISKpn12 in A. baumannii MOS1 
To determine whether a full copy of ISKpn12 is present in MOS1, primers complementary to 
ISKpn12 (Marquez et al., 2008) were designed. ISKpn12F (Table 2.3, Figure 3.18) is 
complementary to sequences in the ISKpn12 tnpA. ISKpn12R3 (Table 2.3, Figure 3.18) is 
complementary to the right-most end of ISKpn12 and includes part of the right inverted repeat. A 
PCR assay (2.6) was carried out using MOS1 and MOS2 genomic DNA as template. A no DNA 
control was included to detect the presence of contamination in the reagents used for the assay. 
Following PCR amplification, the amplicons were analysed by agarose gel electrophoresis (2.3.2; 
Figure 3.19).  
 
Figure 3.19: Agarose gel electrophoresis of amplicons following an ISKpn12F-ISKpn12R3 PCR. Lane 1: 
Hyperladder IV (Bioline; Appendix C); Lane 2: no DNA control; Lane 3: MOS2; Lane 4: MOS1. The arrow indicates 
the expected product size of 735 bp and relevant marker sizes are indicated. 
 
No product was obtained from the no DNA control (Figure 3.19; Lane 2) or from MOS2 (Figure 
3.19; Lane 3), indicating that this element is not present in MOS2. A 735 bp product was 
obtained from MOS1 (Figure 3.19; Lane 4) suggesting the presence of a complete copy of 
ISKpn12 in this A. baumannii strain. The PCR product was therefore extracted from the agarose 
gel (2.3.3) and sequenced (2.7) on both strands (Figure 3.20) to confirm that it corresponds to 
ISKpn12.  
1       2     3    4  
 1        2       3         4 
1 000 bp 
100 bp 
700  bp 
ISKpn12F-R3 
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Analysis of the sequencing data obtained (Figure 3.20) indicated the presence of a full copy of 
ISKpn12 in MOS1. Thus, MOS1 has a full copy of ISKpn12 upstream of the aacC2a-associated 
conserved  genetic arrangement. 
ISKpn12 has only been described in an MDR K. pneumoniae strain 12836 from Uruguay, South 
America (Figure 3.21a; Márquez et al., 2008). This is the first study that describes ISKpn12 in 
A.baumannii. Interestingly, this element was part of a plasmid in an A. baumannii isolate, 7037 
(Figure 3.21b; Poirel et al., 2007), however, ISKpn12 was not described in that study. The 
sequence containing ISKpn12 was obtained when a novel β-lactamase, blaSCO-1 was identified in 
A. baumannii 7037.  
 
 
Figure 3.21: Schematic representation of the genetic environment of ISKpn12 in a) K. pneumoniae 12836. aacC2a, 
aminoglycoside resistance gene;  insertion sequence element, ISKpn11; δ, RNA polymerase sigma factor; insertion 
sequence element, ISKpn12; dbp, DNA-binding protein; ∆umuD,  partial UV mutagenesis-encoding gene (Adapted 
from Márquez et al., 2008);  b) A. baumannii 7037.   blaSCO-1, β-lactamase resistance gene; tnpR, Tn21-related 
sequence; insertion sequence element, ISKpn12; umuD-like, gene encoding a UV mutagenesis-like protein; umuC, 
UV mutagenesis-encoding gene (Adapted from Poirel et al., 2007).  The direction of transcription is indicated by 
arrows.  
 
Some IS elements like ISAba-1 in Acinetobacter (Segal et al., 2005) and  IS2000 in 
K. pneumoniae (Aubert et al., 2003) have only been described in one bacterial genera or 
species, suggesting that these elements are unique to these species. The identification of 
aacC2a ∆ umuD dbp δ factor ISKpn11 ISKpn12 
a. 
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ISKpn12 in A. baumannii MOS1 and A. baumannii 7037, and in K. pneumoniae 12836 suggests 
that this IS element is not confined to a particular species or genus, but rather that it is shared 
between different genera. IS elements may become specific to certain organisms if they are 
located on plasmids that are not transferable across bacterial species or genera (Segal et al., 
2005; Snyder & Champness, 2002). The identification of ISKpn12 in K. pneumoniae and 
A. baumannii suggests that this element may have been transferred on a plasmid that can 
replicate in both K. pneumoniae and A. baumannii and points at K. pneumoniae as a source of 
this element in A. baumannii (Segal & Elisha 1999).  
Interestingly, A. baumannii 7037 that haboured ISKpn12 was also isolated from a patient in 
South America. IS elements including, IS1542 (UK/Ireland; Darini et al., 1999), IS1251 (USA; 
Mackinnon et al., 1997), and IS1476 (Canada; Mackinnon et al., 1997), have been obtained from 
bacterial isolates contained within particular geographical areas. Our detection of ISKpn12 in an 
A. baumannii isolate from South Africa indicates that this mobile genetic element is not confined 
to South America or K. pneumoniae. 
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3.4 Prevalence and detection of ISKpn12 in A. baumannii clinical isolates and other 
clinically significant pathogens 
To determine the prevalence of ISKpn12 in A. baumannii, a PCR assay (2.6) using ISKpn12F 
and ISKpn12R primers (Table 2.3; Figure 3.20) was carried out on genomic DNA from 
A. baumannii isolates obtained from hospitals in Cape Town (Table 2.1). MOS2 genomic DNA 
and a no DNA PCR assay were included as negative controls. MOS1 genomic DNA was 
included as a positive control. Following PCR amplification, the PCR products were analysed on 
a 2 % agarose gel (2.3.2; Figure 3.22).  
 
 
Figure 3.22: PCR amplicons following an ISKpn12F-R PCR on A. baumannii clinical isolates. Lane 1: sHyperladder 
IV (Bioline; Appendix C); Lane 2: A1; Lane 3: A2; Lane 4: A3; Lane 5: A4; Lane 6: A5; Lane 7: A7; Lane 8: A9; 
Lane 9: A10; Lane 10: A19; Lane 11: A40; Lane 12: A91; Lane 13: 794; Lane 14: MOS1; Lane 15: MOS2; Lane 
16: no DNA control. A 230 bp product (arrow) indicates a positive result. Relevant marker sizes are indicated.  
 
No amplicons were obtained from the no DNA control (Figure 3.22; Lane 16) and the negative 
control, MOS2 (Figure 3.22; Lane 15). A product of 230 bp, corresponding to ISKpn12, was 
obtained from the positive control, MOS1 (Figure 3.22; Lane 14). Similarly, 230 bp products were 
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the presence of the ISKpn12 tnpA in these isolates. No 230 bp products were obtained for strains 
A3, A4, A7, A9, A10, A19, A40, and 794  (Figure 3.22; Lanes 4, 5, 7, 8, 9, 10, 11, and 13, 
respectively), indicating that these strains do not harbour ISKnp12.  
A more recent A. baumannii isolate, 794, was included in this assay. This isolate was obtained in 
2008 from a patient at Red Cross War Memorial Children’s Hospital and is resistant to all 
clinically useful antibiotics (Table 2.1) except colistin. The use of aminoglycosides to treat 
A. baumannii infections has decreased in hospitals. This is due to the increase of MDR isolates 
that can only be inhibited by other antibiotics apart from aminoglycosides. Reduced use of 
aminoglycosides to treat A. baumannii infections may be associated with the subsequent loss of 
aminoglycoside resistance genes (Jacobson, 2007). The absence of a 230 bp product from 
A. baumannii 794 (Figure 3.22; Lane 13) indicates the absence of the ISKpn12-IS1133L/ISAba-
1/IS1133R-aacC2a conserved genetic arrangement. This genetic arrangement may have been 
lost by recent A. baumannii isolates due to the reduced use of aminoglycosides at hospitals in 
Cape Town (Jacobson, 2007). 
Interestingly, isolates A2, A5, and A91 had a 230 bp PCR product (Figure 3.22). These isolates 
contain the IS1133L/ISAba-1/IS1133R-aacC2a arrangement (Figure 3.1) and belong to the same 
PFGE profile as MOS1 (Jacobson, 2007; personal communication from H. Segal). The presence 
of a 230 bp PCR product in these isolates provides further evidence that ISKpn12 is part of the 
genetic arrangement that has been conserved since 1983 in A. baumannii clinical isolates from 
Cape Town.  
The observed results indicate that a lineage of A. baumannii isolates from hospitals in Cape 
Town harbours an ISKpn12-IS1133L/ISAba-1/IS1133R-aacC2a. This genetic arrangement may 
be responsible for resistance to gentamicin in these A. baumannii isolates. The absence of this 
genetic arrangement in MOS2 and in the more recently obtained isolate 794 suggests the use of 
alternative aminoglycoside-resistance mechanisms (Table 1.1; Bergogne-Berezin & Towner, 
1996) like overexpression of the AdeABC multidrug efflux pump (1.3.2; Magnet et al., 2001), 
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K. pneumoniae has a 56–58 % GC content (Murray et al., 1984). The G + C content of ISKnp12 
is 57 % as determined by sequence analysis (2.7), indicating its likely source to be 
K. pneumoniae. This value differs significantly from that of the A. baumannii core genome, which 
is 39 % (Fournier et al., 2006). Foreign DNA acquired by A. baumannii can be determined by a 
deviation from the 39 % G + C content of the core genome (Fournier et al., 2006; Schmidt & 
Hensel, 2004). The observed difference in the G + C content suggests that A. baumannii MOS1 
may have acquired ISKnp12 from other pathogens, particularly K. pneumoniae. The presence of 
ISKpn12 in other pathogens was therefore investigated.  
Genomic DNA (provided by H. Segal) from representative isolates of E. coli, P. aeruginosa, 
K. pneumoniae, and C. jejuni  (Table 2.2) isolated from patients from Cape Town hospitals were 
screened for the presence of ISKpn12.  The environmental isolates A. lwoffii and 
A. calcoaceticus (Table 2.2) were also included to determine the presence of this element in 
representative isolates from the genus Acinetobacter. A PCR assay (2.6) using 16S universal 
primers 16SF-16SR (Table 2.3) was carried out to determine the integrity of the DNA. MOS1 was 
included as a positive control. A no DNA control was included to determine the presence of 
contamination. Following PCR amplification, the amplicons were analysed by agarose gel 
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Figure 3.23: Agarose gel electrophoresis photo of 16S PCR-amplified genomic DNA from bacteria from various 
genera Lane 1; Hyperladder IV (Bioline; Appendix C); Lane 2: no DNA control; Lane 3-6: E. coli; Lane 7-14: 
P. aeruginosa; Lane 15-19: K. pneumoniae; Lane 20: Campylobacter jejuni; Lane 21: A. lwoffii; Lane 22-23: 
A. calcoaceticus; Lane 24: MOS1. A 449 bp product (arrow) indicates a positive result. The relevant marker sizes 
are indicated. 
 
No product was obtained from the no DNA control (Figure 3.23; Lane 2), indicating the absence 
of contamination in the reagents used for this assay. A product of 449 bp, corresponding to 16S 
rRNA, was obtained from the positive control, MOS1 (Figure 3.23; Lane 24). Similarly, 449 bp 
products were obtained from all isolates screened for the presence of 16S rRNA, except for 
C. jejuni (Figure 3.23; Lane 20), indicating that the quality of the DNA was good enough for use 
in PCR assays. All samples, including C. jejuni, were included in a PCR assay (2.6) to screen for 
the presence of ISKpn12. 
Genomic DNA from MOS1 and A91 were included as positive controls as they both contain 
ISKpn12. A no DNA control and MOS2 genomic DNA were included as negative controls. 
Following PCR amplification using ISKpn12F and ISKpn12R primers (Table 2.3), the amplicons 
were analysed on a 2 % agarose gel (2.3.2; Figure 3.24).  
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Figure 3.24: Agarose gel electrophoresis following PCR amplification of ISKpn12 tnpA on pathogenic isolates from 
various genera. Lane 1; Hyperladder IV (Bioline; Appendix C); Lane 2: no DNA control; Lane 3-6: E. coli; Lane 7-
14: P. aeruginosa; Lane 15-19: K. pneumoniae; Lane 20: Campylobacter jejuni; Lane 21: A. lwoffii; Lane 22-23: A. 
calcoaceticus; Lane 24: MOS2; Lane 25: BLANK; Lane 26: MOS1. ; Lane 27: A91; 28: Hyperladder IV (Bioline; 
Appendix C). A 230 bp product (arrow) indicates a positive result. The relevant marker sizes are indicated.  
 
No amplicons were obtained from the no DNA control (Figure 3.24; Lane 2) and the negative 
control, MOS2 (Figure 3.24; Lane 24). A product of 230 bp, corresponding to ISKpn12, was 
obtained from the positive controls MOS1 and A91 (Figure 3.24; Lanes 26 and 27, respectively). 
A product of the expected size was not detected in E. coli (Figure 3.24; Lanes 3-6), 
P. aeruginosa (Figure 3.24; Lanes 7-14), K. pneumoniae (Figure 3.24; Lanes 15-19), C. jejuni 
(Figure 3.24; Lane 20), A. lwoffii (Figure 3.24; Lane 21), or A. calcoaceticus (Figure 3.24; Lanes 
22-23). The results obtained suggest that neither of the isolates included, except for C. jejuni, 
contain ISKpn12. The absence of a 230 bp PCR product from C. jejuni (Figure 3.24; Lane 20) as 
well as from the 16S rRNA PCR assay (Figure 3.23; Lane 20) suggests that the DNA from this 
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The first description of ISKpn12 was in a K. pneumoniae isolate (Figure 3.21a; Márquez et al., 
2008). The K. pneumoniae isolates screened in this study did not contain ISKpn12 (Figure 3.24; 
Lanes 15-19). K. pneumoniae may not be the reservoir for this element in our hospital setting or 
ISKpn12 may have been lost by horizontal gene transfer from the K. pneumoniae strains 
included in this study. However, only five K. pneumoniae isolates were screened for the 
presence of ISKpn12 in this study. It would be necessary to screen a larger population of 
K. pneumoniae isolates to determine if this pathogen might be the reservoir of ISKpn12 in our 
setting.  
An A. baumannii isolate 7037 (Poirel et al., 2007) contains ISKpn12 (Figure 3.21b). This isolate 
was obtained from a patient in a South American hospital, the same geographical region 
K. pneumoniae 12836 was obtained from. Both K. pneumoniae and A. baumannii are soil 
organisms and nosocomial pathogens (Bouvet & Grimont, 1986; Brown & Seidler, 1973; Glew et 
al., 1977). It may be that in South America, ISKpn12 was transferred between K. pneumoniae 
and A. baumannii by horizontal gene transfer either in the soil or the hospital environment. The 
source of ISKpn12, however, remains to be determined.  
That ISKpn12 is present in A. baumannii MOS1 and related strains but absent in A. baumannii 
MOS2 and related strains suggests that this element is part of the conserved genetic 
arrangement associated with aacC2a in A. baumannii. It is interesting to speculate about the role 
of ISKpn12 in the aacC2a-associated conserved genetic arrangement. IS elements often provide 
promoter sequences for antibiotic-conferring resistance genes (Corvec et al., 2003; Depardieu et 
al., 2007; Segal et al., 2005). Since ISKpn12 lies upstream of the aacC2a antibiotic resistance 
gene, it may be that this IS element plays a role in the expression of aacC2a. However, this is 
unlikely as ISKpn12 is 2 645 bp upstream of the aacC2a gene. It is more likely that ISAba-1, 
previously shown to provide promoter sequences for a number of genes, including phaBAC 
(Schembri et al., 1995), blaOXA-23 (Donald et al., 2000; Segal et al., 2007), blaOXA-27 (Afzal-Shah et 
al., 2001), and ampC (Corvec et al., 2003; Segal et al., 2004), is the element that regulates 
expression of aacC2a in MOS1 and related strains. Primer extension analysis experiments are 
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play a role in stabilising the ISKpn12-IS1133L/ISAba-1/IS1133R-aacC2a conserved genetic 
arrangement in MOS1. An increased copy number of IS elements in bacterial cells suggests 
mobility, as determined by Segal and colleagues for ISAba-1 (2004). The copy number of 
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3.5 Investigation of the role of ISKpn12 in A. baumannii strains MOS1  
3.5.1 Detection of ISKpn12 copy number in A. baumannii strain MOS1  
The role of ISKpn12 in relation to the maintenance of the ISKpn12-IS1133L/ISAba-1/IS1133R-
aacC2a genetic arrangement in MOS1 was investigated. A Southern hybridisation (2.8) was 
carried out on EcoRI-digested MOS1 genomic DNA. Importantly, EcoRI does not cleave within 
the ISKpn12 nucleotide sequence. EcoRI-digested MOS2 genomic DNA was included as a 
negative control. The digested genomic DNA was electrophoresed on an agarose gel (2.3.2; 
Figure 3.25a) and transferred to a nitrocellulose membrane (2.8). The labeled ISKpn12F-R probe 
(2.8.1) used for this assay was obtained following PCR amplification using MOS1 genomic DNA 
as template. An agarose gel extracted (2.3.3) ISKpn12F-R PCR product obtained from MOS1 
was included as a positive control.  
230 bp
200 bp














Figure 3.25: Autoradiograph displaying ISKpn12 copy number in A. baumannii MOS1. a) Agarose gel 
electrophoresis of EcoRI digested genomic DNA. Lane 1: Hyperladder I (Bioline; Appendix C); Lane 2: MOS1; Lane 
3: MOS2; Lane 4: BLANK; Lane 5: ISKpn12F-R PCR product. b) Autoradiograph of ISKpn12F-R probe hybridised 
to EcoRI digested A. baumannii strains MOS1 and MOS2. Lane 1: Hyperladder I (Bioline; Appendix C); Lane 2: 
MOS1; Lane 3: MOS2; Lane 4: BLANK Lane 5: ISKpn12F-R PCR product. Relevent marker sizes are indicated and 
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Following Southern hybridisation (2.8) with 300 ng of labeled probe (2.8.2; Figure 3.25b), no 
hybridisation signal was obtained from the negative control, MOS2 (Figure 3.25b; Lane 3), 
providing further evidence that this strain does not contain ISKpn12. A product of the expected 
size (230 bp) corresponding to the ISKpn12F- ISKpn12R (Figure 3.20) PCR product obtained 
from MOS1 yielded a signal (Figure 3.25a and b; Lane 5). Following an overnight exposure of the 
X-ray film, non-specific signals were detected from the PCR product (Figure 3.25b; Lane 5). This 
may be due to the probe binding to non-specifically amplified PCR products that are not visible 
on the agarose gel (Figure 3.25a; Lane 5). A positive hybridisation signal was detected from 
strain MOS1 (Figure 3.25b, Lane 2), corresponding to a fragment greater than 10 000 bp (Figure 
3.25a and b, Lane 2), indicating that MOS1 contains at least one copy of ISKpn12 on an EcoRI 
fragment greater than 10 000 bp. It may be that more than one EcoRI fragment of the same size 
harbours this IS element, resulting in only one hybridisation signal being observed (Figure 3.25b, 
Lane 2). The > 10 000 bp fragment may also contain more than one copy of ISKpn12.  
To further determine the copy number of ISKpn12 in MOS1, a Southern hybridisation (2.8) was 
carried out on EcoRI/HindIII digested MOS1 genomic DNA (Figure 3.26). A HindIII site is present 
within ISKpn12 (Figure 3.20). A probe was generated using ISKpn12F-ISKpn12R2 primers 
(Table 2.3; Figure 3.20) and MOS1 genomic DNA as template. Importantly, the ISKpn12F-











- 96 - 
 
 
Figure 3.26: Autoradiograph of ISKpn12F-R2 probe hybridised to EcoRI/HindIII digested A. baumannii strains 
MOS1 and MOS2. a) EcoRI/HindIII digested genomic DNA. Lane 1: Hyperladder I (Bioline; Appendix C); Lane 2: 
MOS1; Lane 3: BLANK; Lane 4: MOS2; Lane 5-9: BLANK Lane 10: gel purified ISKpn12F-R2 PCR product. b) 
Autoradiograph of ISKpn12F-R2 probe hybridised to EcoRI/HindIII digested A. baumannii strains MOS1 and MOS2. 
Lane 1: Hyperladder I (Bioline; Appendix C); Lane 2: MOS1; Lane 3: BLANK; Lane 4: MOS2; Lane 5-9: BLANK 
Lane 10: gel purified ISKpn12F-R2 PCR product. Relevent marker sizes are indicated and the 704 bp product/signal 
indicated by an arrow. 
 
No product was obtained from the negative control, strain MOS2 (Figure 26b; Lane 4) previously 
shown (Figure 3.19) not to contain a copy of ISKpn12.  A 704 bp product corresponding to the 
region ISKpn12F- ISKpn12R2 was obtained from the PCR product from  
MOS1 (Figure 3.26a and b; Lane 10). Following an overnight exposure of the X-ray film, non-
specific signals were detected (Figure 3.26b; Lane 10). This may be due to the probe binding to 
non-specifically amplified PCR products that are not visible on the agarose gel (Figure 3.26a; 
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(Figure 3.26b, Lane 2). EcoRI/HindIII digestion of MOS1 genomic DNA generated a 1 586 bp 
HindIII fragment (Figure 3.18), amongst many other fragments (Figure 3.26a; Lane 2).  The 
ISKpn12F-ISKpn12R2 probe hybridised to the 1 586 bp HindIII fragment (Figure 3.26a and b; 
Lane 2). Another hybridisation signal was obtained on a fragment ~ 2 400 bp (Figure 3.26a and 
b; Lane 2). The two hybridisation signals obtained (Figure 3.26b; Lane 2) indicate the presence 
of one copy of ISKpn12 in MOS1. If the > 10 000bp fragment (Figure 3.25b; Lane 2) harboured 
more than one copy of ISKpn12, then following digestion with EcoRI and HindIII, these elements 
would be on different sized fragments. This would have resulted in more than two signals being 
obtained with the EcoRI/HindIII Southern hybridisation (Figure 3.26b; Lane 2).  
The presence of one copy of ISKpn12 suggests that this element is not mobile in the MOS1 
genome. This suggests that ISKpn12 may not have a functional role in A. baumannii, even 
though it may be useful in K. pneumoniae.  It is important to note that the preferred promoter 
sequences in K. pneumoniae and E. coli are not the preferred promoter sequences recognized 
by the A. baumannii RNA polymerase (Segal & Elisha, 1999). ISKpn12, together with genes that 
may have been useful to MOS1 and A. baumannii 7037, may have therefore been acquired on 
one mobile genetic element. However, it was interesting to see if the tnpA of ISKpn12 was 
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3.5.2 Expression of ISKpn12 tnpA in A. baumannii MOS1 
DNA sequence analysis (2.7) of pTJ001 (Figure 3.17) revealed the presence of ISKpn12 
upstream of a portion of IS1133 in MOS1 (Figure 3.18; Figure 3.20). Southern hybridisation 
studies (2.8) revealed the presence of one copy of ISKpn12 in A. baumannii MOS1 (Figure 3.25; 
Figure 3.26).  To determine whether the tnpA of ISKpn12 in MOS1 is expressed, reverse 
transcriptase PCR assays were carried out (2.10). RNA was extracted using the hot acid phenol 
method (2.9) from logarithmic and stationary phase cultures of strain MOS1 and MOS2. Any 
contaminating DNA was eliminated by DNase treatment (2.9).  
Controls containing no cDNA and no RNA were included to detect for contamination in the 
reaction. The expression of the 16S rRNA gene was determined using 16S universal primers 
(Table 2.3) and was included as a positive control. Prokaryotic ribosomes have a 30S subunit 
made up of protein and 16S rRNA (Garret & Grisham, 2005). Expression of the I6S rRNA was 
included as a positive control for the presence of RNA since ribosomes are required for protein 
synthesis and are always present in bacterial cells. The primer ISKpn12R (Table 2.3; Figure 
3.20) anneals within the tnpA of ISKpn12 and was used for first strand synthesis of cDNA. The 
primers ISKpn12F and ISKpn12R (Table 2.3; Figure 3.20) were used for PCR amplification of 
tnpA from the reverse-transcribed cDNA. MOS2 does not contain ISKpn12 (Figure 3.19; Figure 
3.25b; Figure 3.26b) and was used as a negative control, and MOS1 included as a positive 
control. Following reverse transcription and PCR amplification, the PCR products were analysed 
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Figure 3.27: Agarose gel electrophoresis of amplicons obtained following reverse transcription PCR of ISKpn12 and 
16S rRNA in MOS1 and MOS2. Lane 1: Hyperladder IV (Bioline; Appendix C); Lane 2: no RNA control; Lane 3: no 
cDNA control; Lane 4: MOS1 logarithmic phase; Lane 5: MOS1 stationary phase; Lane 6: MOS2 logarithmic phase; 
Lane 7: MOS1 genomic DNA; Lane 8: MOS2 stationary phase; (Lanes 9 – 15 display results for 16S Reverse 
transcriptase PCR); Lane 9: no RNA control; Lane 10: no cDNA control; Lane 11: MOS1 logarithmic phase; Lane 
12: MOS1 stationary phase; Lane 13: MOS2 logarithmic phase; Lane 14: MOS2 stationary phase; Lane 15: MOS1 
genomic DNA. Marker sizes are indicated. A 230 bp and 449 bp product corresponding to ISKpn12 tnpA and 16S 
PCR products, respectively are indicated with arrows. 
 
No product was obtained from the no RNA (Figure 3.27; Lane 2 and 9) and no cDNA controls 
(Figure 3.27; Lane 3 and 10) indicating the absence of contamination in the reagents used in this 
assay. This result also indicates the absence of DNA contamination in the RNA used for reverse 
transcriptase PCR. An expected 449 bp product was obtained from MOS1 genomic DNA 
following amplification with the 16S universal primers (Figure 3.27; Lane 15). A product of 449 bp 
was obtained from both MOS1 and MOS2 (Figure 3.27; Lanes 11-14) following PCR 
amplification of the cDNA using 16S universal primers. Thus, the 16S rRNA was synthesised in 
the logarithmic and stationary phase cultures from both strains and the quality of the RNA was 
good enough to use in reverse transcriptase PCR assays to determine ISKpn12 tnpA expression. 
An expected product (230 bp) corresponding to the tnpA of ISKpn12 was obtained from MOS1 
genomic DNA (Figure 3.27; Lane7). No product was obtained from the negative control, MOS2, 
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from MOS1 cDNA synthesised from RNA obtained from both the logarithmic and stationary 
phase cultures (Figure 3.27; Lanes 4 and 5), indicating that ISKpn12 tnpA is expressed in both 
growth phases in MOS1. The PCR product obtained from the logarithmic phase culture (Figure 
3.27; Lane 4) is brighter than that from the stationary phase culture (Figure 3.27; Lane 5). It may 
be that ISKpn12 expression is different in the logarithmic and stationary growth phases. In the 
latter, an increased expression of ISKpn12 would result in more RNA being obtained. To 
determine the latter, real time PCR assay could be carried out. 
Unlike ISKpn12, ISAba-1 is present in A. baumannii isolates in multiple copies (Segal et al., 
2005). This element is unique to Acinetobacter spp. and is considered highly mobile (Segal et al., 
2005). Increased resistance to various antibiotics is achieved through ISAba-1 providing 
promoter sequences for expression of the antibiotic resistance genes (Schembri et al., 1995; 
Donald et al., 2000; Afzal-Shah et al., 2001; Corvec et al., 2003; Segal et al., 2004 and 2007; Le 
Hello et al., 2008; Niumsup et al., 2009). ISAba-1 may be responsible for the plasticity observed 
in the A. baumannii genome (Segal et al., 2005) by rearranging genes and contributing to the 
formation of transposons (Corvec et al., 2007). Since ISAba-1 is associated with the aacC2a-
associated conserved genetic arrangement in MOS1 (Figure 3.1), its role was investigated in 
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3.6 Investigation of the role of ISAba-1 in A. baumannii strains MOS1 and MOS2 
ISAba-1 is a 1 180 bp IS element that belongs to the IS4 family, according to the IS 
nomenclature proposed by Mahillon and Chandler (1998). This insertion sequence has only been 
described in Acinetobacter spp.. ISAba-1 encodes a transposase with similarity to a putative 
transposase from Deinococcus radiodurans (Segal et al., 2003), a common soil organism. 
Acinetobacter spp. are also found in the soil and this might reflect the source of this insertion 
sequence (Segal et al., 2003).  
ISAba-1 is associated with a variety of antibiotic resistance genes, where it plays a role in the 
expression of these genes by providing alternative promoter sequences (Corvec et al., 2003; 
Segal et al., 2004; Le Hello et al., 2008; Niumsup et al., 2009). A copy of ISAba-1 interrupts 
IS1133 in the conserved genetic arrangement in A. baumannii MOS1 (Figure 3.1).  Primers 
complementary to the ISAba-1 tnpA, HRR and HRF (Table 2.3; Figure 3.28), were used in a 

























Figure 3.28: Nucleotide sequence of ISAba-1. The inverted repeats are underlined and in bold blue text. 
Highlighted in green are the primers HRF and HRR and their direction is indicated by the arrows. The numbers on 
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This insertion sequence is present in MOS2 (Jacobson, 2007), yet MOS2 does not contain the 
ISKpn12-IS1133L/ISAba-1/IS1133R-aacC2a genetic arrangement.  In MOS2, ISAba-1 has been 
identified upstream of blaOXA-23 where it provides additional promoter sequences for expression 
of this β-lactamase resistance gene (Segal et al., 2007). To determine whether ISAba-1 is mobile 
in MOS1 and MOS2, reverse transcriptase PCR assays evaluating the expression of ISAba-1 
tnpA were carried out (2.10). RNA was extracted using the hot acid phenol method (2.9) from 
logarithmic and stationary phase cultures of strain MOS1 and MOS2. Any contaminating DNA 
was eliminated by DNase treatment (2.9).  
Controls containing no cDNA and no RNA were included to detect for contamination in the 
reaction. The expression of the 16S rRNA gene was determined using 16S universal primers 
(Table 2.3) and was included as a positive control. The primer HRR (Table 2.3; Figure 3.28) 
anneals within the tnpA of ISAba-1 and was used for first strand synthesis of cDNA. The primers 
HRF and HRR (Table 2.3; Figure 3.28) were used for PCR amplification of tnpA from the 
reverse-transcribed cDNA. MOS1 was included as a positive control. Following reverse 
transcription and PCR amplification, the PCR products were analysed on a 2 % agarose gel 













- 104 - 
 
 
Figure 3.29: Agarose gel electrophoresis of amplicons obtained following reverse transcription PCR of ISAba-1 and 
16S rRNA in MOS1 and MOS2. Lane 1: Hyperladder IV (Bioline; Appendix C); Lane 2: no RNA control; Lane 3: no 
cDNA control; Lane 4: MOS1 logarithmic phase; Lane 5: MOS1 stationary phase; Lane 6: MOS2 logarithmic phase; 
Lane 7: MOS2 stationary phase; Lane 8: MOS1 genomic DNA; (Lanes 9 – 15 display results for 16S Reverse 
transcriptase PCR). Lane 9: no RNA control; Lane 10: no cDNA control; Lane 11: MOS1 logarithmic phase; Lane 
12: MOS1 stationary phase; Lane 13: MOS2 logarithmic phase; Lane 14: MOS2 stationary phase; Lane 15: MOS1 
genomic DNA. Marker sizes are indicated. Products of 550 bp and 449 bp corresponding to ISAba-1 tnpA and 16S 
PCR products from positive controls, respectively are indicated with arrows. 
 
No product was obtained from the no RNA (Figure 3.29; Lane 2 and 9) and no cDNA controls 
(Figure 3.29; Lane 3 and 10) indicating the absence of contamination in the reagents used in this 
assay. This result also indicates the absence of DNA contamination in the RNA used for reverse 
transcriptase PCR. An expected 449 bp product was obtained from MOS1 genomic DNA 
following amplification with the 16S universal primers (Figure 3.29; Lane 15). A product of 449 bp 
was obtained from both MOS1 and MOS2 (Figure 3.29; Lanes 11-14) following PCR 
amplification of the cDNA using 16S universal primers. Thus, the 16S rRNA was synthesised in 
the logarithmic and stationary phase cultures from both strains and the quality of the RNA was 
good enough to use in reverse transcriptase PCR assays. 
An expected product (550 bp) corresponding to the tnpA of ISAba-1 was obtained from MOS1 
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obtained from MOS1 and MOS2 cDNA synthesised from RNA obtained from both the logarithmic 
and stationary phase cultures (Figure 3.29; Lanes 4-7), indicating that ISAba-1 tnpA is expressed 
in both growth phases in these two strains. The PCR product obtained from the logarithmic 
phase culture of MOS1 (Figure 3.29; Lane 4) is brighter than that for MOS2 (Figure 3.29; Lane 
6). It may be that there are different expression levels for ISAba-1 in the growth phases of these 
two strains. To determine the latter, a real-time PCR, assay which accurately determines DNA 
expression levels, could be carried out. The observed differences in the intensity of the 550 bp 
product obtained may also be a result of the presence of different copy numbers in these two 
strains where a higher copy number would be associated with an increased expression level. 
The copy number of ISAba-1 was therefore investigated. 
It has been previously reported that an increased distribution of ISAba-1 in A. baumannii isolates 
may aid creation of composite transposons (Corvec et al., 2007). Since MOS1 and MOS2 may 
harbour large antibiotic resistance elements, determining the copy number of ISAba-1 would 
provide further evidence for the presence of large resistance genomic regions in MOS1 and 
MOS2. A Southern hybridisation (2.8) was carried out on EcoRI/BamHI-digested MOS1 and 
MOS2 genomic DNA (Figure 3.30). Importantly, there are no EcoRI or BamHI restriction sites 
within the ISAba-1 sequence. The labeled HRF- HRR probe (2.8.1) used for this assay was 
obtained following PCR amplification using MOS1 genomic DNA as template. An agarose gel 
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Figure 3.30: Autoradiograph displaying ISAba-1 copy number in A. baumannii MOS1 and MOS2. a) EcoRI/BamHI 
digested genomic DNA. Lane 1: Hyperladder I (Bioline; Appendix C); Lane 2: MOS1; Lane 3: BLANK; Lane 4: 
MOS2; Lane 5-7: BLANK Lane 8: gel purified HRF-HRR PCR product. b) Autoradiograph of HRF-HRR probe 
hybridised to EcoRI/BamHI digested A. baumannii strains MOS1 and MOS2. Lane 1: Hyperladder I (Bioline; 
Appendix C); Lane 2: MOS1; Lane 3: BLANK; Lane 4: MOS2; Lane 5-7: BLANK Lane 8: gel purified HRF-HRR 
PCR product. Relevent marker sizes are indicated and the 550 bp product/signal indicated by an arrow. 
 
A product of the expected size (550 bp) corresponding to an HRF-HRR PCR product was 
obtained for the positive hybridisation control (Figure 3.30a and b; Lane 8). There were 12 
hybridisation signals obtained from MOS1 (Figure 3.30b; Lane 2), indicating the presence of at 
least 12 copies of ISAba-1 in this strain. A total of 10 hybridisation signals were obtained for 
MOS2 (Figure 3.30b; Lane 4), indicating the presence of at least 10 copies of ISAba-1 in this 
strain. The copy number, nonetheless, may be underestimated as the strongly hybridising bands 
(Figure 3.30b; Lanes 2 and 4) may contain more than one copy of ISAba-1. It was not surprising 
that MOS1, which is resistant to fewer antibiotics than MOS2, might have more copies of ISAba-
1 since at least eight copies of this element have been observed in an A. lwoffii non-resistant 
isolate (Segal et al., 2005).Thus, ISAba-1 copy number in Acinetobacter spp. is not an indication 
of antibiotic resistance, but of genomic plasticity. That MOS1 may have more copies of ISAba-1 
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than MOS2 may explain the observed difference in expression levels of this element (Figure 
3.29). It may be that the more resistant A. baumannii isolates have more stable genomes as the 
ISAba-1 elements are integrated and associated with antibiotic resistance genes to provide 
promoter sequences for their expression. In addition, the susceptible isolates may have more 
unstable genomes, with more copies of ISAba-1, as they try to adapt to the toxic hospital 
environment. It would be interesting, however, to determine the copy number of ISAba-1 in more 
MDR isolates, especially from various geographic regions.  
 
Although specific to A. baumannii, ISAba-1 has a pivotal role of transposing and providing 
promoter sequences for antibiotic resistance genes, even those acquired from other pathogens 
(Corvec et al., 2007). Contrary to the role it might play in mobilising genomic regions, ISAba-1, 
together with ISKpn12, may be responsible for stabilizing the ISKpn12-IS1133L/ISAba-
1/IS1133R-aacC2a conserved genetic element present in A. baumannii strain MOS1 (Jacobson, 
2007). Thus, ISAba-1 has more than one role in A. baumannii strain MOS1.  In MOS2, ISAba-1 
is responsible for the observed resistance to carbapenems by providing alternative promoter 
sequences to blaOXA-23 (Segal et al., 2007). ISAba-1 may also be involved in mobilizing genomic 
regions in MOS2, however, this may be to a lesser extent than in MOS1, given the differences in 
expression levels (Figure 3.29) and copy number (Figure 3.30).  
 
IS1133 was first described on a Tn5393 transposon in the plant pathogen Erwinia amylovora 
(Chiou & Jones, 1993) in America. It was later described in A. baumannii strains in South Africa 
(Segal et al., 2003), Salmonella enterica strains obtained from animals in Italy (Pezzella et al., 
2004), and Salmonella enterica isolated from European patients (Doublet et al., 2008). It is 
noteworthy that in the Salmonella enterica isolates from Europe (Pezzella et al., 2004; Doublet et 
al., 2008), IS1133 was located on Tn5393 or Tn5393-like structures. Interestingly, IS1133 from 
A. baumannii isolates obtained from South Africa is interrupted by a full copy of ISAba-1 and may 
not be associated with Tn5393, but possibly with Tn21 (Figure 3.3),as determined by sequence 
analysis (2.7). The role of IS1133 in A. baumannii MOS1 has been reported (Jacobson, 2007). 
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3.1), since it is interrupted by a full copy of ISAba-1 (Jacobson, 2007) and there is a T-A 
transversion in the right inverted repeat of this element (Segal et al., 2003).  
 
The ISKpn12-IS1133L/ISAba-1/IS1133R-aacC2a conserved genetic element represents an 
interesting mosaic structure of an aminoglycoside resistance gene associated with; ISAba-1 
that’s unique to A. baumannii, IS1133 that has been identified in plant, animal, and human 
pathogens, and ISKpn12 that’s been identified in clinical pathogens and may have originated 
from K. pneumoniae. In the absence of whole genome sequencing, the sequences upstream of 
this arrangement in MOS1 could be characterised further by constructing other genomic DNA 
libraries using different combinations of restriction enzymes. On the other hand, enriched cloning 
could be used to increase the chances of obtaining sequences upstream of ISKpn12. Sequences 
downstream of the ISKpn12 HindIII site (Figure 3.20) lie within a fragment ~2 400 bp (Figure 
3.26b; Lane 2) as revealed by Southern hybridisation of EcoRI/HindIII digested MOS1 genomic 
DNA. This genomic fragment has a HindIII site on one end that lies within ISKpn12. The ~2 400 
bp fragment has either an EcoRI or a HindIII site on the other end. Following agarose gel 
extraction and purification (2.3.3) of this fragment, it could be used in two separate cloning 
experiments using HindIII- and EcoRI/HindIII-digested pUC19.  The recombinants obtained could 
then be screened by PCR for sequences upstream of ISKpn12 using the primers ISKpn12F2 and 
ISKpn12R2 (Figure 3.20). Positive recombinants harbouring ISKpn12 would contain sequences 
upstream of this element, and possibly a recombination site as previously proposed (3.2; Figure 
3.9).  
Sequencing and sequence analysis could also be used to identify sequences upstream of 
ISKpn12. Since a single copy of this element is present in MOS1 (Figure 3.25; Figure 3.26), the 
sequences upstream of ISKpn12 could be characterised by sequencing MOS1 genomic DNA. 
Initially, the primer ISKpn12F or ISKpn12F2 (Figure 3.20) could be used to sequence the 
genomic DNA on one strand. The presence of one copy of ISKpn12 means that the primer used 
for sequencing, ISKpn12F or ISKpn12F2, will only yield sequences upstream of this element. 
Based on the initial sequencing results, more primers could then be designed and used to 
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It would be interesting however, to know if this conserved region lies on a plasmid or on the 
chromosomal DNA. Some portions of large resistance regions are located on plasmids or are 
excised from the chromosomal DNA and exist as independent units (Chen et al., 2008; Iacono et 
al., 2008; Ronan & Boyd, 2008; D’ Andrea et al., 2009). Genomic DNA electrophoresed on an 
agarose gel did not reveal the presence of plasmid DNA (Figure 3.4; Lane 2), however, 
additional studies need to be conducted to determine the location of this large conserved genetic 
arrangement. This would provide interesting clues to the origin or role of this aacC2a-associated 
conserved genetic arrangement in a particular lineage of aminoglycoside resistant A.  baumannii 
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SUMMARY AND CONCLUSION 
 
A genetic arrangement, IS1133L/ISAba-1/IS1133R-aacC2a, has been described in A. baumannii 
clinical isolates obtained from patients admitted to hospitals in Cape Town since 1983. 
A. baumannii isolates that have this genetic arrangement are resistant to gentamicin and 
amikacin. In 2005, a carbapenem susceptible strain, MOS1, was obtained from a patient at GSH. 
MOS1 harboured this conserved genetic arrangement associated with aacC2a. Following two 
weeks of treatment with meropenem, an A. baumannii strain MOS2 was obtained from the same 
patient. MOS2 did not contain the conserved genetic arrangement. However, it had an ISAba-1-
associated blaOXA-23 gene and was resistant to imipinem and meropenem.  
The IS1133L/ISAba-1/IS1133R-aacC2a arrangement has a G+C content of 47 % compared to 
that of 39 % for A. baumannii (Fournier et al., 2006). This suggests that the sequence comprises 
foreign DNA that may have been acquired by MOS1. This foreign DNA may well be part of a 
larger mobile genetic element such as a transposon or PAI. The absence of this genetic 
arrangement in MOS2, and the presence of ISAba-1-associated blaOXA-23 suggests that the 
former may have been replaced by the latter through a recombination event when these strains 
originally diverged.  
The ATPase gene in A. baumannii may be interrupted by insertion of large genomic regions 
including PAIs and transposons (Fournier et al., 2006; Corvec et al., 2007; Iacono et al., 2008; 
Shaikh et al., 2009). The primers 42-156F and 46-358R (Fournier et al., 2006) flank a 253 bp 
region within the ATPase gene where such large genomic regions may be inserted. To determine 
whether the ATPase gene was interrupted in MOS1 and MOS2, a PCR assay using these 
primers was carried out. Following a number of optimisations including increasing the annealing 
time to allow for amplification of larger products, no PCR amplicon was obtained from either 
strain, suggesting that the ATPase genes in these strains are disrupted, possibly by a large 
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A. baumannii isolates yielded no PCR products (Fournier et al., 2006). The presence of an 
ATPase gene interrupted by large mobile genetic elements was suggested and confirmed using 
whole genome sequencing. In a similar study, a PCR assay on 10 MDR A. baumannii isolates 
using primers that flank the ATPase gene no PCR products were obtained (Shaikh et al,. 2009). 
However, further studies revealed the presence of an interrupted ATPase gene in eight of the 10 
isolates. 
Sequences downstream of the aacC2a-associated conserved genetic arrangement have been 
characterised (Segal et al., 2003). Primers on either side of this region were used, in combination 
with the ATPase-specific primers (Fournier et al., 2006), in PCR assays to identify further 
sequences that may be associated with putative transposons or PAIs in MOS1. Though no 
product was obtained, further assays using strains with both an intact and a disrupted ATPase 
gene with known sequence need to be carried out to determine whether these strains harbour 
interrupted ATPase genes and hence large genomic insertions.  
In the absence of whole genome sequencing and since the sequences downstream of the 
IS1133L/ISAba-1/IS1133R-aacC2a conserved region in MOS1 have been characterised (Segal et 
al., 2003), a standard cloning procedure (Sambrook et al., 1989) was used to detect sequences 
upstream of this genetic arrangement. 
When screening an EcoRI/HindIII genomic DNA library of A. baumannii MOS1, one recombinant 
plasmid was identified and designated pTJ001. Sequence analysis of the genomic DNA fragment 
in pTJ001 revealed the presence of a partial ISKpn12 element 558 bp upstream of the left 
inverted repeat of IS1133. To determine whether a full copy of this element was present in 
MOS1, primers were designed to amplify a full copy of ISKpn12. A full copy of ISKpn12, 
associated with the aacC2a-linked conserved genetic region, was identified in MOS1 and not in 
MOS2, suggesting that ISKpn12 is part of the conserved genetic arrangement associated with 
MOS1 and related strains from our hospitals.  Detection of ISKpn12 in a selection of MOS1-
related isolates and not in MOS2-related isolates further supports the fact that this element is 
associated with the aacC2a-associated genetic arrangement conserved in A. baummannii 
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The first report of ISKpn12 was from a K. pneumoniae isolate obtained from Uruguay, South 
America (Márquez et al., 2008). In silica genomic DNA analysis identified this element as a part 
of a plasmid in an A. baumannii isolate, 7037 obtained from a patient in Argentina, South 
America (Poirel et al., 2007). Since ISKpn12 was not described in that study, this is the first 
report of this element in A. baumannii. Our detection of ISKpn12 in an A. baumannii isolate from 
South Africa indicates that this insertion sequence element is neither confined to South America 
nor to a particular genus, raising interesting questions about the origin, spread and role of this 
element in A. baumannii. 
Since the G+C content of ISKpn12 (57 %) differs significantly from that of A. baumannii (39 %; 
Fournier et al., 2006), it was likely that A. baumannii MOS1 and related isolates obtained this 
element from other pathogens. However, ISKpn12 was not detected in representative isolates of 
E. coli, P. aeruginosa, K. pneumoniae, A. lwoffii, and A. calcoaceticus as determined by PCR 
assays.  Interestingly, the K. pneumoniae isolates screened in this study did not contain 
ISKpn12, suggesting that K. pneumoniae might not be the reservoir for this IS element in our 
setting. However, a more thorough investigation comprising a larger number of K.pneumoniae 
isolates from the same time periods and hospitals as the A. baumannii isolates included in this 
study needs to be conducted to determine whether K. pneumoniae is the source of ISKpn12 in 
A. baumannii. 
Since ISAba-1 provides alternative promoter sequences for resistance genes, it was interesting 
to investigate if ISKpn12 had the same role in A. baumannii. The tnpA of ISKpn12 is expressed 
in both the logarithmic and stationary phases of growth in MOS1. However, only one copy of this 
IS element was detected in MOS1, suggesting that it is not mobile and may not provide promoter 
sequences for the aacC2a gene in the conserved genetic arrangement. Besides, ISKpn12 is too 
far upstream of the aacC2a gene in the conserved genetic arrangement and so most likely does 
not play this role in A. baumannii. ISKpn12 may therefore be involved in stabilizing the aacC2a-
associated conserved genetic arrangement in MOS1 and related strains, even though this 
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Interestingly, ISAba-1 in MOS1 may also be involved in stabilizing the the conserved genetic 
arrangement in MOS1where it disrupts an IS1133 element (Jacobson, 2007). In addition, ISAba-
1 may be responsible for genome plasticity in the less resistant A. baumannii isolate, MOS1, 
since at least 12 copies of this element were detected. ISAba-1 may have a different role in 
MOS2 since this isolate does not contain the ISKpn12-IS1133L/ISAba-1/IS1133R-aacC2a genetic 
arrangement. It is known that in MOS2, ISAba-1 is responsible for the observed resistance to 
carbapenems by providing alternative promoter sequences to blaOXA-23 (Segal et al., 2007). The 
other roles of this element in MOS2 remain to be determined. However, the presence of at least 
ten copies, and what seemed to be a reduced expression level of this element in MOS2 
compared to MOS1 suggests ISAba-1 may also be responsible for genomic plasticity in MOS2, 
though to a lesser extent than in MOS1. The observed differences in the copy number and 
expression of ISAba-1 in MOS1 and  MOS2 may be an indication of how resistant an 
Acinetobacter spp. may be.  However, that both MOS1 and MOS2 had a high copy number of 
ISAba-1 points to the possibility that both strains harbour large resistance genomic islands 
(Corvec et al., 2007).  
ISKpn12 exists as a single copy in MOS1 and is associated with an aacC2a-conserved genetic 
region. This suggests that ISKpn12 has no other roles in MOS1 than that of possibly stabilizing 
the conserved genetic region. The presence of this element, together with a highly mobile ISAba-
1 in the same genetic arrangement that has been conserved for over 23 years in A. baumannii 
isolates from Cape Town represents a structure that was once useful to A. baumannii before the 
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APPENDIX A 
Media, buffers and solutions 
2 X YTryptone agar 
Yeast extract   10 g 
Tryptone   16 g 
NaCl      5 g 
Agar    15 g 
Make up to 1 litre with distilled water and autoclave 
 
2 X Tryptone broth 
Yeast extract   10 g 
Tryptone   16 g 
NaCl      5 g 
Make up to 1 litre with distilled water and autoclave 
 
50 X TAE buffer 
Tris    242 g 
Glacial acetic acid  57.1 ml 
0.5 M EDTA   100 ml 
Make up to 1 litre with distilled water 
 
Denaturing buffer 
NaCl    87.66 g 
NaOH    10 g 
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Depurinating buffer 
HCl    21.6 ml 
Make up to 1 litre with distilled water 
 
LB agar    
Yeast extract   5 g 
Tryptone   10 g 
NaCl    10 g 
Agar    15 g 
Make up to 1 litre with distilled water and autoclave 
 
LB broth 
Yeast extract   5 g 
Tryptone   10 g 
NaCl    10 g 
Make up to 1 litre with distilled water and autoclave 
 
Neutralising buffer (pH 7.5) 
NaCl    87.66 g 
Tris    60.58 g 
Make up to 1 litre with distilled water  
 
Prehybridization buffer (depending on the size of membrane being used) 
ECL blocking agent  5 % (w/v) 
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Make up to the required volume with ECL hybridisation buffer  
 
Primary wash buffer 
Urea    360 g 
SDS       4 g 
Make up to 1 litre with distilled water  
 
Secondary wash buffer 
20 X SSC   100 ml 
Make up to 1 litre with distilled water  
 
20 X SSC (pH 7) 
Sodium citrate    88.23 g 
NaCl    175.32 g 
Make up to 1 litre with distilled water  
 
SOC medium (pH 7) 
Yeast extract   0.5 g 
Tryptone   2.0 g 
1M NaCl   1 ml 
1M KCl    0.25 ml 
Bring to 97 ml with distilled water, autoclave and cool to room temperature. Add Mg2+ stock and 
2M glucose. Filter through a 0.2μm filter unit and store at 4oC 
Mg2+ stock   1 ml 
(Mg2+ stock: 1M MgCl2.6H2O, 1M MgSO4.7H20: filter sterilised) 
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TE buffer (pH 8) 
1M Tris-HCl   5 ml 
1M EDTA   5 ml 
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APPENDIX C 
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AAGCTTTCTACTGCGGAGTTATCAAAACAATTGCCTTTCCCGCTCATGGACGGCAGCAATTGATGTTTGAGCAGTAGCTTTTGATATTCATGAGCGCAAT    100 
ATTGGCTCCCACGGTCTGTGTGTTGAATACAACCCGGTGGTGGTTTGCGTAAAGCCAACGCCATATTCAGTGCCCTTAATGCAAGATCCTGCTTTAATCG    200  
ATCACCTGTTGCCCAGCCAATCACGCGACGGGAATACAGGTCAAGGATAACAGCAAGATAGACCCATCCTTCTCTGGTCCAAACATAAGTGATATCGCCT    300 
GCCCATTTCTGGTTGGGTGCGCTTGCGCTAAAGTCTTGTTTTAATAGGTTCGGTGCAATGTTGAAGGTATGATGACTATCCGTTGTCCGTTTGAATTTAC    400 
GCGTTCGAACAACTGTAATGTTATTCTGGCGCATCAAACGTCCAACCCGACGCTGCCCAACCTGCAGGCCCAGCGCTTTCAACTCTTCTGTCATACGCGG    500 
CCTACCATAGCTCCCCAAACACAACCGATGCTGCTCACGTATATGCGCTAGAAGTATAAGATCACGACGCTGGCGCAGTGATGGAGGACGGCGTTTCCAT    600 
GCACGTAAACCACGATCTGTTACGCCCATCAAACGACATATGCGTGAACGTGAGAGAGAGCCACGGTAATCCGTAATAAACTGAAATCTCACAGCTTTTG    700 
TACTGCGAAAAATATTGCTGCCTTTTTTAATATCTCCCTCTCCTCCCGAAGGATACGGTTCTCTTTGCGTAAACGTTCATTCTCACGCAGAAGATCAGTG    800 
TCTTGGGTAGGAATTTTAGTTTCATCGGAAATTGATGCGATCCATTTCCCAAGCGTGGAAAGCCCAATACTTAAATCTGACGCAACTTGACGGCGTGTTA    900 
AGCCACTAGTGAGTGCTATGCGAACTGCATCACGCTTAAATTCATCACTATGCTTTAATGACATATATGGTCTCCTTGATAACAAATAATGCTCTCAAAA   1000 
AGACCGGAACGAAACCGAGGCAAGTCCATTTATCCGCGTCGTCTCGCCGCCCGCTCCGCCTCCGCGCGAATAGCAAGCAGCGAAGGACCAAGAAGCTCAC   1100 
GCGCATGAGCGACCGTTTCGGCGGATGCCGTGTTTAGGGTCAGGACCCATTGATTTGAACTGACGGCTGTGATTCAGATGGGCGTATAGGAGCCCGACTG   1200 
      GGGTCAGGACCCATTGATTTGAACTGACGGCTGTGATTCAGATGGGCGTATAGGAGCCCGACTG    64 
ATGAGTAATTTGTTTTGGCTGACGGACGAGCAAATGGCTCGTCTTCAGCCCTATTTCCCCAAGAGCCATGGCCGCCAGCGCGTTGATGATCGACGCGTTC   1300 
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TGAGCGGCATCATCTTCGTCAACCGCAACGGGCTGCGTTGGCGTGATGCGCCGAAGGAATATGGCCCGGCGAAGACGCTTTATAACCGCTGGAAACGCTG   1400 
TGAGCGGCATCATCTTCGTCAACCGCAACGGGCTGCGTTGGCGTGATGCGCCGAAGGAATATGGCCCGGCGAAGACGCTTTATAACCGCTGGAAACGCTG   264 
GGGCGACAAGGGCGTATTTATCCAGATGATGGAAGGTCTGGCCGTGCCTGAAGCCGCAGAGCACAAGACCATCATGATCGATGCGACCTATCTCAAGGCC   1500 
GGGCGACAAGGGCGTATTTATCCAGATGATGGAAGGTCTGGCCGTGCCTGAAGCCGCAGAGCACAAGACCATCATGATCGATGCGACCTATCTCAAGGCC   364 
CACCGCACGGCTTCCAGCTTGCGGGTAAAAAAGGGGGCGCGGGCCGCCTGATTGGACGCACGAAAGGCGGCATGAACACCAAGCTT    1586 
CACCGCACGGCTTCCAGCTTGCGGGTAAAAAAGGGGGCGCGGGCCGCCTGATTGGACGCACGAAAGGCGGCA GAACACCAAGCTTCATGCCGTAACGGA   464 
TGCGAGTGGTCGCCCGATCAGCTTCTTCATAACGGCAGGCCAGGTCAGCGATTACACCGGTGCTGCCGCCTTGCTTGATGAACTTCCCAAGGCCAAATGG   564 
TTGCTGGCCGACCGTGGCTATGATGCCGACTGGTATCGTGACGCTTTACAGGCGAAGGGGATCACTCCCTGCATTCCAGGTCGAAAATCCCGCAAGAAGA   664  
CCATCAAATACGACAAACGCCGCTACAAACGGCGCAACCGGATCGAGATCATGTTCGGGCGTCTCAAAGACTGGCGGCGTGTCGCTACGCGTTACGACCG   764 
GTGCCCAATGGCCTTTCTCTCCGCCATCGCTCTCGCTGCGACCGTTATCTTCTGGCTATGAGCAATGAGTCCTGACCC                          842          
 
Figure3.18: Nucleotide sequence of a 1 586 bp HindIII insert in pTJ001 showing 100 % homology to ISKpn12. The HindIII sites on either side of the insert are highlighted in red, the primers 
IS1133F2 and IS1133F5 are highlighted in yellow. The left inverted repeat of IS1133 is underlined and in pink text. The tnpA in IS1133 is indicated by the start codon CAT in red text, the 
stop codon lies downstream of the HindIII site. The published sequence of ISKpn12 is in green text. The left inverted repeat of ISKpn12 is underlined and in blue text. An ISKpn12 tnpA is 
indicated by the start and stop codons, ATG and TGA respectively, in red text. Highlighted in green are ISKpn12- specific primers used in PCR assays and for sequence analysis. The 
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Figure 3.20: Nucleotide sequence alignment of ISKpn12 from MOS1 and the published sequence. There is 100 % homology between the two sequences, indicated 
by the black highlighting. The inverted repeats are underlined and a HindIII site is highlighted in red. Sequences upstream of the HindIII site were part of the 1 586 bp 
fragment obtained in pTJ001, and includes the 351 bp tnpA indicated by ATG and TGA in red text. The primers used for sequencing and PCR assays are highlighted 
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CTCTGTACACGACAAATTTCACAGAACCCTTATCCTATCAGGGTTCTGCCTTCTTAAAATTGCCAAAATTTCCTTAAACTCTTCTTTTTTCCCAAAACCA    100 
ATTAAACGCTGAATCGCCATTTGAACATAGTCTAAACCATAGCGAAATAAACTCATTGAGAGTCGTCCATGCTTCTTTATTTTTATCGCTTTTTTTTGAT    200 
CATGTTGCCATTCACCCGTTAAGTAACACCAACAGAAGCTTATAGCTAACACCGCAATCAATTTTTTCACTCGTCTAGGGTCTGTCAAGCGCGTATTTTC    300 
AAGATTAAACCCGCGTCCTTTGAGACAACTGAATAAGGTTTCAATTTCCCAGCGTAATGCATAATCCTGAATAGCATTGGCATTAAACTGAGGAGAAACG    400 
ACGAGTAAAAGCTCTCCATTTTCTAACTGTAGTGCACTTATATATAGTTTCACCCGACCAACCAAAATCCGTCGTTTACGACATTCAATTTGACCAACTT    500 
TAAGATGGCGAAATAAATCACTAATTTTATGATTCTTTCCTAAATGATTGGTGACAATGAAGTTTTTTTAACACGAATGCAGAAGTTGATGTCTTGTTCA    600 
ATTAACCATGTAAACCACTGCTCACCGATAAACTCTCTGTCTGCGAACACATTCACAATACGGTCTTTACCAAAAATGGCTATAAAGCGTTGAATCAAAG    700 
CAATACGCTCTTTCGTATCTGAATTTCCACGTTTATTAAGCAATGTCCAAAGGATAGGTATCGCTATTCCACGATAAACGATTGCGAGCATCAGGATATT    800 
AATATTTCGTTTTCCCCATTTCCAATTGGTTCTATCTAAAGTCAGTTGCACTTGGTCGAATGAAAACATATTGAAAATCAACTGAGAAATTTGACGATAA    900 
TCAAAATACTGACCTGCAAAGAAGCGCTGCATACGTCGATAAAATGATTGTGGTAAGCACTTGATGGGCAAGGCTTTAGATGCAGAAGAAAGATTACATG   1000 
TTTGCTTTAAAATAATCACAAGCATGATGAGCGCAAAGCACTTTAAATGTGACTTGTTCCATTTTAGATATTTGTTTAAGATAAGATATAACTCATTGAG   1100 
ATGTGTCATAGTATTCGTCGTTAGAAAACAATTATTATGACATTATTTCAATGAGTTATCTATTTTTATCGTGTACAGAG                       1180 
 
 
Figure 3.28: Nucleotide sequence of ISAba-1. The inverted repeats are underlined and in blue text. Highlighted in green are the primers HRF and HRR and their direction is indicated by the 
arrows. An ISAba-1 tnpA is indicated by the start and stop codons, CAT and CTA respectively, in red text. The numbers on the right hand side indicate nucleotide bases. 
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HRR 
ISAba-1-IRL 
 
ISAba-1-IRR 
 
ISAba-1 tnpA 
